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ABSTRACT
Pathway to Allostery:  Differential Routes for Allosteric Communication in
Phosphofructokinase from Escherichia coli.
 (December 2004)
Nilubol Monique Paricharttanakul, B.S., Texas A&M University
Chair of Advisory Committee:  Dr. Gregory D. Reinhart
Phosphofructokinase from Escherichia coli (EcPFK) is allosterically regulated
by MgADP and phospho(enol)pyruvate (PEP).  Both molecules compete for binding to
the same allosteric site, however, MgADP activates and PEP inhibits the binding of
fructose-6-phosphate (F6P) to the active site.  The mode by which this enzyme can
differentiate between the two ligands and cause the appropriate response is important for
the understanding of the basis of allosteric regulation.
We studied the interactions between an active site and an allosteric site
(heterotropic interactions) within the protein, and found that each of the four unique
heterotropic interactions is unique and the magnitudes of the coupling free energies for
MgADP activation sum up to 100% that of wildtype EcPFK without homotropic
cooperativity in F6P binding.  We took on the kinetic and structural characterization of
phosphofructokinase from Lactobacillus bulgaricus (LbPFK) to reveal an enzyme that
exhibits allosteric properties in spite of previous kinetic studies performed by Le Bras et
al. (1991).  We have identified residues in EcPFK (Asp59, Gly184 and Asp273), which
iv
are important for the allosteric responses to both MgADP and PEP.  Interestingly,
Lys214 is only important in PEP inhibition and not MgADP activation.  We can also
differentially disrupt the MgADP heterotropic interactions with the introduction of
G184C within the protein.  These results suggest that there are different pathways for
allosteric communication within the enzyme: different paths for MgADP activation and
PEP inhibition, and different paths for each heterotropic interaction with Gly184 being
important for the 33Å MgADP heterotropic interaction.
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NOMENCLATURE
Abbreviations
A Generally denotes substrate or single letter code for alanine
ADP Adenosine 5’-diphosphate
Ala Alanine
AMP Adenosine-5’-monophosphate
Arg Arginine
Asp Aspartate
ATP Adenosine 5’-triphosphate
BCA Bicinchoninic Acid
BsPFK Phosphofructokinase from Bacillus stearothermophilus
C Single letter code for cysteine
D Single letter code for aspartate
DTT Dithiothreitol
E Generally denotes enzyme or single letter code for glutamate
EcPFK Phosphofructokinase from Escherichia coli
EDTA Ethylenediamine tetraacetic acid
EPPS N-(2-hydroxy-ethyl)piperazine-N'-(3-propanesulfonic acid)
F Single letter code for phenylalanine
F6P Fructose-6-phosphate
FBP Fructose-1,6-bisphosphate
ix
G Single letter code for glycine
GDP Guanosine 5’-diphosphate
Glu Glutamate
Gly Glycine
H Single letter code for histidine
His Histidine
I Single letter code for isoleucine
K Single letter code for lysine
KSCN Potassium thiocyanate
L Single letter code for leucine
LB Luria Bertani broth
LbPFK Phosphofructokinase from Lactobacillus bulgaricus
Leu Leucine
Lys Lysine
M Single letter code for methionine
MES 2-(N-morpholino)ethanesulfonic acid
Met Methionine
MOPS 3-[N-Morpholino]propanesulfonic acid
N Single letter code for asparagine
NAD+ Nicotinamide adenine dinucleotide (oxidized form)
NADH Nicotinamide adenine dinucleotide (reduced form)
P Generally denotes product or single letter code for proline
xPAGE Polyacrylamide gel electrophoresis
PEP Phospho(enol)pyruvate
PFK Phosphofructokinase
PGA Phosphoglycolate
Phe Phenylalanine
Q Single letter code for glutamine
R Single letter code for arginine
S Single letter code for serine
SDS Sodium dodecyl sulfate
Ser Serine
T Single letter code for threonine
Tris Tris[hydroxymethyl]aminomethane
TtPFK Phosphofructokinase from Thermus Thermophilus
UTP Uridine 5’-triphosphate
V Single letter code for valine
W Single letter code for tryptophan
X Generally denotes activator
Y Generally denotes inhibitor or single letter code for tyrosine
xi
Mathemathical Terms
† 
Kia
o Thermodynamic dissociation constant for A in the absence of effector
† 
Kia
• Thermodynamic dissociation constant for A in the saturating presence of
effector
† 
Kix
o Thermodynamic dissociation constant for X in the absence of substrate
† 
Kix
• Thermodynamic dissociation constant for X in the saturating presence of
substrate
† 
Kiy
o Thermodynamic dissociation constant for Y in the absence of substrate
† 
Kiy
• Thermodynamic dissociation constant for Y in the saturating presence of
effector
c Torsion angle
°C Degree Celsius
Å Angstroms
F Structure factor
I Intensity
K0.5 Concentration of substrate to produce half-maximal activity
kcat Turnover number of the enzyme
kDa Kilodalton
Ki Inhibition constant
Km Michaelis constant
mg Milligram
mL Milliliter
mM Millimolar
xii
nH Hill number
nm Nanometer
Qax Coupling constant for the interaction between A and X
Qay Coupling constant for the interaction between A and Y
R Gas constant
Rfree Free R-factor
rmsd Root mean square deviation
Rsym Error in measured intensities of equivalent reflections
T Temperature
U Units
v Initial velocity
V• Maximal velocity in the saturating presence of effector
Vmax Maximal velocity
Vo Maximal velocity in the absence of effector
Wax Coupling constant for the interaction between A and X which alters the
maximal velocity
DGax Coupling free energy for the interaction between A and X
DGay Coupling free energy for the interaction between A and Y
mL Microliter
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1CHAPTER I
INTRODUCTION
The study at the molecular level of chemical processes in living organisms is the
science of biochemistry.  In living organisms, the four major complex biomolecules
found in cells and tissues are proteins, nucleic acids, polysaccharides and lipids.  All
these complex biomolecules are made up of small molecules that combine in repeating
units of each other.  Amino acids are the building blocks of proteins.  Deoxyribonucleic
acids (DNA) and ribonucleic acids (RNA) contain deoxyribonucleotides and
ribonucleotides, respectively.  Sugars form polysaccharides, and lipids are made up of
fatty acids.  The study of these complex biomolecules, the determination of their
structures and the investigations into their function is what biochemistry is all about.
Proteins are the most abundant biomolecules in many organisms, e.g., humans
(Murray et al, 1996) and Escherichia coli (Voet and Voet, 1995).  They play many major
cellular and structural functions.  One of their important roles is as enzymes that mediate
the many biochemical reactions required for proper function of the cell.  Enzymes
catalyze specific biochemical reactions or types of reactions without being consumed in
the process.  This specificity allows for the rates of biological processes to be regulated
by changes in the levels or catalytic efficiency of specific enzymes.  For example, the
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2hydroxylation of phenylalanine to tyrosine is catalyzed by phenylalanine hydroxylase.
In infants with phenylketonuria, a heritable disorder that results in signs of mental
retardation, the levels of liver phenylalanine hydroxylase average approximately 25% of
normal levels, and the hydroxylase is insensitive to regulation by phenylalanine (Murray
et al., 1996).  Phenylalanine hydroxylase is very specific for phenylalanine as its
substrate.  It can hydroxylate tryptophan to a small extent, but not tyrosine (Daubner et
al, 2000).  Due to the abundance of enzymes in the cell and their medical importance,
many scientists have devoted themselves and their resources to the study of enzymes and
how they work.
Cells control the balance necessary for correct function in response to changing
environmental factors and nutritional levels by regulating the level of enzymes or the
activity of enzymes.  The right balance between the rate of enzyme synthesis from amino
acids and the rate of enzyme degradation determines the quantity of an enzyme available
in the cell.  On the other hand, the catalytic efficiency of enzymes can be altered as a
result of changing levels of substrates and metabolites in the cell.  Enzyme activity can
also be modulated by conformational changes caused by covalent modifications, protein-
protein interactions and allosteric regulation.  One such enzyme that exhibits two of the
above-mentioned types of regulation is glycogen phosphorylase.  This enzyme can be
covalently modified by the phosphorylation at Ser14 by phosphorylase kinase resulting
in glycogen degradation and the dephosphorylation by phosphoprotein phosphatase.
Glycogen phosphorylase is also subject to allosteric regulation.  It is allosterically
activated by AMP and inhibited by ATP and glucose-6-phosphate (Voet and Voet,
31995).  An example of regulation by protein-protein interactions is phosphoprotein
phosphatase which is inhibited by its binding to phosphoprotein phosphatase inhibitor
(Voet and Voet, 1995).
One of the ways enzymes are subject to stringent control in the cell is through
allosteric regulation.  Allosteric regulation is triggered by ligands known as effectors that
bind to specific sites remote from the substrate-binding site on an enzyme and cause the
enzyme to be activated or inhibited.  The effects on the specific activity of the enzyme
(V-type) and/or the binding of substrate (K-type) to the enzyme are two types of
allosteric effects that are possible.  K-type effects are most common (Reinhart, 2004).
Homotropic effects are observed when two ligands are identical and can result in
cooperativity in ligand binding.  Positive cooperativity is represented by sigmoidal
binding profiles and occurs when the binding of the first ligand increases the binding
affinity for the second.  When there is no cooperativity i.e., no influence in the binding
affinity of the first ligand to the subsequent ligand, the binding profiles are hyperbolic.
Negative cooperativity is observed when the subsequent binding affinity decreases and
can be seen by a shallow slope in the binding profiles (Reinhart, 2004).
When the ligands are different from one another, the allosteric effect is described
to be heterotropic.  The binding of an allosteric ligand can cause the binding of substrate
to increase (K-type activation) or decrease (K-type inhibition), and vice versa.  The
cooperative responses generated by the binding of heterotropic ligands are known as
heterotropic cooperativity and can be found in two classes: heterotropically induced
homotropic cooperativity and subsaturating heterotropic cooperativity.  The first class
4arises when the binding of the effector changes the coupling between substrate binding
sites, and can be negative or positive depending on how the effector changes the
coupling between the active sites.  The latter occurs at intermediate concentrations of the
effector and is positive regardless of the nature of the heterotropic interaction (Reinhart,
1988).
Models for Allosteric Regulation
Traditionally, there are two models used to describe allosteric response, the
concerted (MWC) and sequential (KNF) models.  Both models claim that there are two
functional conformational states, the T-state or “taut” state and the R-state or relaxed
state.  The T-state is the inhibited state of the protein and results when the inhibitor is
bound to the enzyme.  The R-state is the active form of the enzyme to which the
substrate and activator can bind.  These two models presume that the enzyme can adopt
either the R-state or the T-state conformation.
The concerted model (Monod et al., 1965) states that for an oligomeric protein,
all subunits are functionally identical.  The two conformational states that the protein can
adopt are in equilibrium with one another (Figure 1-1A) even in the absence of bound
ligand.  The binding of substrate to its binding site shifts the equilibrium of the oligomer
to the R-state in a concerted manner and exhibits positive cooperativity.  When an
activator binds to the enzyme, the equilibrium is shifted towards the R-state facilitating
substrate binding.  Cooperativity is not observed for substrate binding in the presence of
activator because the enzyme is already in the R-state.  However, when inhibitor binds to
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FIGURE 1-1: Schematic diagram of the MWC concerted model and the KNF sequential
model for allosteric regulation of a tetrameric protein.  L represents any ligand.  (A) In
the concerted model, all the subunits are postulated to be in one conformation, either all
£ (high affinity or active) or ô (low affinity or inactive).  Depending on the equilibrium
between £ and ô forms, the binding of one or more ligands will pull the equilibrium to
the R-state (left) or to the T-state (right).  In the presence of substrate or activator, the
equilibrium is shifted to the left, and to the right with inhibitor.  (B) The sequential
model allows for each individual subunit to be in either the £ or ô form.  Each subunit
can undergo the conformational change individually.  The binding of ligand causes an
induced fit in the subunit it binds to and in neighboring subunits.  The complete
transition from one state to the other requires the binding of ligand to all sites. (Adapted
from Lehninger et al., 1993)
6the enzyme, the equilibrium is shifted more towards the T-state, decreasing the sites
available for substrate binding, thereby increasing the cooperativity of substrate binding.
Only positive cooperativity is allowed in the MWC model. The sequential model
(Koshland et al., 1966) assumes an induced fit scenario in which binding of a ligand to
one subunit of the enzyme induces a conformational change in that subunit (Figure 1-
1B).  The influence that this conformational change has on neighboring subunits can be
positive or negative depending on the identity of the ligand.  Conformational changes
occur sequentially for binding to the remaining subunits and are proportional to the
number of ligands bound.  The complete conversion from one state to another is
observed only when all sites are filled.
These oversimplified models do not accurately depict the nature of all allosteric
enzymes.  Thermodynamic linkage (Wyman, 1964; Weber, 1972, 1975) serves as a more
complete analysis for the investigation of allosterism.  This linked function approach
describes ligand binding in free energy terms without assuming the nature of structural
changes incurred by ligand binding.  The basic principle of thermodynamic linkage is
that the influence the substrate (A) has on the binding of effector (X) to the enzyme (E)
must equal that of X on the binding of A to E as shown in Figure 1-2.  There are four
ligation states that the enzyme can adopt: E, EA or XE or XEA.  Each ligation state is
unique and can have different properties.  This is in contrast to the two-state models
which do not allow for the existence of the ternary complex because the T-state or the R-
state of the enzyme could only bind one type of ligand, either A or X, but not both.
Dissociation constants for each binding event can be written (Reinhart, 1983):
7AE E P+E-A+
A
X
X-E
+ +
X
+ X-E P+
Kix
o
Kix
•
Kia
o
Kia
•
FIGURE 1-2:  The simplest scheme depicting a single substrate and a single allosteric
effector.  E, A, X and P represents enzyme, substrate, effector and product, respectively.
The respective dissociation constants are denoted by K’s and are described in the text
(Reinhart, 1983).
8† 
Kia
o =
[E][A]
[EA]
[1-1]
† 
Kia
• =
[XE][A]
[XEA]
[1-2]
† 
Kix
o =
[E][X]
[XE]
[1-3]
† 
Kix
• =
[EA][X]
[XEA]
[1-4]
† 
Qax =
Kia
o
Kia
• =
Kix
o
Kix
• [1-5]
where Kiao and Kia• are the dissociation constants of A when there is no X present and
when there is saturating X, respectively.  Kixo and Kix• are the dissociation constants of X
in the absence and in the saturating presence of A, respectively.  The magnitude of the
interaction between A and X can be quantified by the coupling constant Qax, the
influence A has on the binding of X and vice versa.  Qax also represents the
thermodynamic equilibrium constant for the following disproportionation equilibrium
(Reinhart, 1989):
X-E + E-A Û X-E-A + E [1-6]
† 
Qax =
[XE][EA]
[XEA][E]
[1-7]
X acts as an activator when Qax > 1 and is an inhibitor when Qax < 1. When Qax = 1, A
and X do not influence each other’s binding.  The magnitude of the interaction between
ligands can be described in free energy terms by the equation (Reinhart, 1983, 1985,
1988, 1989):
9† 
DGax = -RTlnQax [1-8]
where DGax is the free energy of interaction or coupling free energy (Weber, 1972, 1975;
Reinhart, 1983, 1988).  When DGax < 0, X acts as an activator and when DGax > 0, X acts
as an inhibitor.
The rate equation for this mechanism, shown in Figure 1-2, can be written if the
substrate is assumed to achieve rapid equilibrium during steady-state (Reinhart, 1983):
† 
v = V
o(Kix
o [A]+ QaxWax[A][X])
Kia
o Kix
o + Kix
o [A]+ Kia
o [X]+ Qax[A][X]
[1-9]
where v is the initial velocity, V° and V• are the maximal activity in the absence of X
and the saturating presence of X, respectively and W is the ratio of V•  over V°.  When
maximal activity is affected by the allosteric ligand, W will not be equal to 1.
Experimentally the coupling constant, Qax, can be obtained by determining the
apparent dissociation constants for the substrate A as a function of effector concentration
and can be graphically depicted for X being an inhibitor or an activator (Figure 1-3).
The apparent dissociation constant for substrate, K0.5 is the concentration at which the
velocity is at half maximum and is described by the Hill equation (Hill, 1910):
† 
v
ET
=
kcat[A]
n H
K0.5
n H + [A]n H
[1-9]
where v is the rate of the reaction, ET is total enzyme active sites, kcat is the turnover
number and nH is the Hill number that depicts cooperativity in substrate binding.  When
nH > 1, positive cooperativity is observed, and when nH < 1, negative cooperativity is
observed.  When nH = 1, K0.5 is equivalent to the Michaelis constant Km.  Assuming that
the rapid-equilibrium is valid, the dependence of the apparent dissociation constants on
10
0.1
1
10
100
0 0.001 0.01 0.1 1 10 100 1000
K
0.
5 (
m
M
)
[Inhibitor]
A
Kia
o
Kia
•
Kix
o
Qax
0.001
0.01
0.1
1
0 0.001 0.01 0.1 1 10 100 1000
K
0.
5 (
m
M
)
[Activator]
Kia
o
Kix
o Kia
•
Qax
B
FIGURE 1-3: Graphical representation for the determination of the coupling constant
Qax.  The apparent dissociation constant for substrate K0.5 increases as a function of
inhibitor (A) and decreases as a function of activator (B) when the rapid-equilibrium
assumption is valid.  Qax is the difference between the two plateaus that are defined by
Kiao and Kia•.  The dissociation constants for the two effectors Kixo are labeled on the
graphs.
11
effector concentration can be described by the following equation (Reinhart, 1983, 1985,
1988, 1989, 2004):
† 
K0.5 = Kia
o Kix
o + [X]
Kix
o + Qax[X]
È 
Î 
Í 
˘ 
˚ 
˙ [1-10]
Phosphofructokinases
Phosphofructokinase (PFK) plays a key regulatory role in glucose metabolism.
PFK catalyzes the first committed step in glycolysis as shown in Figure 1-4 with the
phosphorylation of fructose-6-phosphate (F6P) by MgATP leading to the formation of
fructose-1,6-bisphosphate and MgADP.  The importance of this enzyme demands for the
presence of a system of checks and balances of enzymatic activity in order to respond to
changing levels of substrates or products in the cell.  It is therefore crucial that in many
organisms, PFKs are subject to allosteric regulation by numerous metabolites.
Eukaryotic PFKs are usually homotetrameric enzymes with twice the size of
prokaryotic PFKs, proposed to be evolutionarily derived from gene duplication of
prokaryotic homologs (Poorman et al, 1984), and can form higher order polymeric states
(Uyeda, 1979).  They are allosterically regulated by a large number of effectors.  AMP,
cyclic AMP, MgADP, inorganic phosphate, fructose-6-phosphate and fructose-1,6-
bisphosphate are allosteric activators.  Inhibitors include citrate, phosphocreatine, 3-
phosphoglycerate, 2-phosphoglycerate, 2,3-bisphosphoglycerate, phospho(enol)pyruvate
(PEP), MgATP and UTP (Uyeda, 1979).
Bacterial PFKs are homotetramers with subunit molecular weights of 34 kDa and
12
Glucose
Fructose-6-phosphate
Fructose-1,6-bisphosphate
Phospho(enol)pyruvate
MgATP
MgADP
Phosphofructokinase(+)
(-)
FIGURE 1-4:  The reaction phosphofructokinase catalyzes.  MgADP activates and PEP
inhibits bacterial PFKs.
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are allosterically activated by MgADP and MgGDP, and inhibited by PEP (Blangy et al,
1968; Uyeda, 1979; Tlapak-Simmons and Reinhart, 1998; Johnson and Reinhart, 1994,
1997).  Two extensively characterized bacterial PFKs are from Escherichia coli
(EcPFK) and Bacillus stearothermophilus (BsPFK).  A K-type allosteric effect is
observed in the presence of MgADP or PEP in both enzymes (Blangy et al, 1968;
Tlapak-Simmons and Reinhart, 1998).  MgADP and PEP compete for binding to the
same allosteric site, and once bound, MgADP increases the binding affinity for substrate,
F6P, whereas PEP decreases F6P binding.  How these enzymes distinguish between the
two molecules and how these molecules induce their respective responses in the
enzymes are questions that still need to be addressed.
EcPFK and BsPFK exhibit many similar characteristics.  They show 73%
similarity and 54% identity in amino acid sequence.  The crystal structures of both
enzymes have been solved and their structures are very similar based on the a-carbon
superimposition of the two structures (Evans et al, 1981; Shirakihara and Evans, 1988).
Figure 1-5 shows the tetrameric structure of EcPFK.  Both PFKs are homotetramers with
four active sites and four allosteric sites that form at subunit interfaces. Each site is
composed of two half sites from each monomer to complete that site to which substrate
or effector binds.  PFK is a dimer of dimers with the active site interface being weaker
than the allosteric site interface and can be stabilized by F6P.  PEP however, stabilizes
the allosteric site interface.  The dissociation of the tetramer into dimers occurs with the
loss of activity, and further dissociation into monomers occurs in the presence of
denaturants: guadinidium chloride, potassium thiocyanate (KSCN) and urea following
14
FIGURE 1-5: Crystal structure of EcPFK homotetramer (Shirakihara and Evans, 1988).
The four subunits are represented in blue, green, red and yellow.  MgADP binds to the
four active sites and allosteric sites and is shown in purple, whereas the product fructose-
1,6-bisphosphate binds only to the active sites and is in grey.
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circular dichroism and fluorescence measurements performed on EcPFK (Teschner et
al., 1990; Le Bras et al, 1989; Deville-Bonne et al, 1989). Because there are four active
sites and four allosteric sites that are capable of communicating with one another, there
are twenty-eight possible pair-wise interactions between binding sites in EcPFK and
BsPFK.  This makes the understanding of allosteric communication within the protein
complex.  Of the twenty-eight, twelve interactions are homotropic or between like-
binding sites (Figure 1-6A) and sixteen are heterotropic or between an active site and an
allosteric site (Figure 1-6B).  However, there are only ten unique interactions, six
homotropic (Figure 1-6C) and four heterotropic (Figure 1-6D), due to the symmetries
present within the protein.  This multiplicity of interactions must be simplified to study
only the four unique heterotropic interactions in order to understand exactly how
allosteric information is transmitted between one active site and one allosteric site.
The differences between EcPFK and BsPFK lie in their kinetic and allosteric
properties.  EcPFK is more active than BsPFK by almost two-fold (Valdez et al, 1989).
In the absence of effectors, positive cooperativity is observed for the binding of F6P to
EcPFK with a Hill number of 3.8 (Blangy et al, 1968) that is dependent on the presence
of ATP (Johnson and Reinhart, 1992), but no such cooperativity is observed for BsPFK
(Valdez et al, 1989).  PEP does not influence the positive cooperativity in F6P binding in
EcPFK, however, subsaturating heterotropically induced homotropic cooperativity is
observed for BsPFK in which positive cooperativity in F6P binding is observed only at
intermediate concentrations of PEP (Reinhart, 1988, Kimmel and Reinhart, 2001).
MgADP does not affect F6P binding to the same extent between the two enzymes.  In
16
A B
B
A D
C B
A D
C
C D
B
A D
C B
A D
C
FIGURE 1-6:  Two-dimensional representation of the PFK tetramer.  The active site
interface lies vertically and the allosteric site interface lies horizontally.  The complexity
of interactions found within the enzyme is comprised of (A) multiple homotropic
interactions (B) multiple heterotropic interactions (C) unique homotropic interactions
and (D) unique heterotropic interactions.
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BsPFK, MgADP activation is barely noticeable at room temperature as compared to
EcPFK.  At higher temperatures, the magnitude of activation in BsPFK increases.  No
activation was observed at 16°C, however at temperatures below 16°C, MgADP
becomes an inhibitor.  This temperature-induced crossover of allosteric response by
MgADP (Braxton et al, 1994) is not observed in EcPFK.  Figure 1-7 shows the
differences in the allosteric responses to PEP and MgADP between the two enzymes at
25°C and pH 8.0.  The extent of PEP inhibition is greater and MgADP activation is
smaller for BsPFK than EcPFK.  The allosteric properties in BsPFK are dependent on
pH, unlike those in EcPFK (Deville-Bonne et al, 1991; Tlapak-Simmons and Reinhart,
1998).
The crystal structures of BsPFK with substrate bound (so-called R-state) and that
with a PEP analog, phosphoglycolate, bound (so-called T-state) have revealed two
conformations of the active site (Evans and Hudson, 1979; Schirmer and Evans, 1990).
In the presence of phosphoglycolate, there is a 7° rotation along one axis and the
position of residues Glu161 and Arg162 in the active site switch between the two
structures.  For many years, this switch was proposed to be the mechanism for allosteric
inhibition by PEP in BsPFK.  The favorable interactions between Glu161 and Arg243,
and Glu161 and Arg252 are proposed to close the active site from F6P binding and
therefore lock the structure in the T-state (Schirmer and Evans, 1990). However,
thermodynamic, kinetic and mutagenic studies have proven the mechanism incorrect
(Kimmel and Reinhart, 2000).  No such mechanism was proposed for EcPFK.
Extensive mutational analyses of both enzymes have been performed by many
18
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FIGURE 1-7: Allosteric properties of EcPFK and BsPFK at pH 8.0 and 25°C.  The
circles are data for EcPFK, the squares are data that pertains to for BsPFK (Tlapak-
Simmons and Reinhart, 1998).  Errors are plotted on the points.  Data was fit to equation
1-10.  Both EcPFK and BsPFK are inhibited by PEP (A) and activated by MgADP (B) to
different extents.
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groups to probe for residues important for binding of substrates and effectors (Valdez et
al, 1988, 1989, Lau and Fersht, 1989, Berger and Evans, 1992, Wang and Kemp, 1999,
Fenton et al., 2003).  Traditionally, MgGDP was used instead of MgADP, because
MgGDP is presumed not to bind to the active site, and therefore specific for binding in
the allosteric site (Blangy et al., 1968, Auzat et al, 1997).  Tables 1-1 and 1-2 summarize
the kinetic characterization of mutations in the active site and the allosteric site,
respectively in EcPFK.  However, not much work has been done to study the role internal
residues play in enabling allosteric communication (Serre et al, 1990, Auzat et al, 1994,
Pham et al., 2001).  A summary of the mutations characterized which are not in the
binding sites in EcPFK can be seen in Table 1-3.  All but one were in the subunit
interface.  Therefore, our goal in this dissertation is to increase our understanding of the
basis for allosteric regulation in EcPFK by simplifying the complex allosteric
communications in EcPFK and shedding light on the path or residue(s) important for
allostery.
Non-allosteric Phosphofructokinases
Even though phosphofructokinases have been isolated and studied from many
different organisms, they show certain similarities in size and homotetrameric structure.
However, phosphofructokinases that are not allosterically regulated have been reported in
bacteria and eukaryotes over the years.  Phosphofructokinases from Dictylostelium
discoideum (Baumann and Wright, 1968), Arthrobacter cystallopoietes (Ferdinandus and
Clark, 1969), Lactobacillus casei,  Lactobacillus plantarum (Doelle, 1972),
Desulfurococcus amylolyticus (Hansen and Schönheit, 2000) and Aeropyrum pernix
20
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(Hansen and Schönheit, 2001) do not exhibit allosteric properties.  Isozymes of PFK from
E. coli (Babul, 1978) and Thermus thermophilus (Xu et al, 1991) are also found to be
non-allosteric.
Phosphofructokinase from Lactobacillus delbrueckii subspecies bulgaricus
(LbPFK) was reported to be non-responsive to MgGDP or MgADP.  Inhibition of activity
by PEP was observed at pH 6 but not at pH 8.2 (Le Bras et al, 1991).  This organism is a
gram-positive, facultative anaerobic bacterium that is important in the food and dairy
industry for the fermentation of milk by converting lactose to lactic acid (Delley and
Germond, 2002).  This lactic acid bacterium does not possess an extensive respiratory
chain, tricarboxylic acid or glyoxylate cycle.  This bacterium does not use gluconeogenic
sources and its carbon sources are only glucose, fructose, lactose and galactose (Le Bras
et al, 1991, Burgos-Rubio et al., 2000).  The inhibition of LbPFK by PEP observed at low
pH could be needed to control intracellular pH during fermentation (Le Bras et al., 1991).
The amino acid sequence of this relatively non-allosteric PFK is 47% identical
and 66% similar to that of EcPFK, and 56% identical and 74% similar to that of BsPFK.
Knowing that the sequence, structure and function of EcPFK and BsPFK are very similar,
we can hypothesize that LbPFK would also have similar structure and function with
EcPFK and BsPFK.  However, LbPFK exhibits diminished allosteric responses as
compared to EcPFK and BsPFK.  Understanding the binding and allosteric behavior of
LbPFK in response to MgADP and PEP, and comparing the sequence and structure of
LbPFK should help in the understanding of the structural basis for allosteric regulation in
EcPFK and/or BsPFK.
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Chapter Overview
Chapter II discusses the materials, experimental procedures and data analyses
used in this dissertation for the kinetic characterization of EcPFK to address how
allosteric communication is transmitted within EcFPK.
The focus of Chapter III is the isolation and characterization of two of the four
unique heterotropic interactions in EcPFK with respect to their allosteric responses to
MgADP as compared to a control created for the wildtype EcPFK without homotropic
cooperativity in F6P binding (Fenton and Reinhart, 2002; Fenton et al., 2004).  These two
combined with the other two heterotropic interactions characterized by my colleague, Dr.
Aron Fenton, would allow for a better understanding on how activation is transmitted
within the tetramer by measuring the coupling free energies of each heterotropic
interaction.
The four unique heterotropic interactions with respect to PEP inhibition had been
characterized for BsPFK.  The magnitudes of the coupling free energies for each of the
unique heterotropic interactions are unique and sum up to the magnitude of the coupling
free energy of a control hybrid without homotropic cooperativity in PEP binding
(Kimmel and Reinhart, 2001; Ortigosa et al, 2004).
Chapter IV is the study of the structure-function relationship in PFK from
Lactobacillus bulgaricus.  The re-examination into the allosteric properties of this
enzyme and the determination of its crystal structure are presented to provide insight into
the structural basis for allosteric regulation in EcPFK and BsPFK.
Chapter V describes the kinetic characterization of mutant proteins of EcPFK in
which amino acids in EcPFK have been substituted by their corresponding amino acids
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from LbPFK to see if we could create proteins with little or no allosteric characteristics
and thereby identifying residues that play important roles in allosteric communication.
Sequence alignment between three bacterial allosteric PFKs including EcPFK, BsPFK
and PFK from Thermus thermophilus, and LbPFK has provided twenty-two conserved
residues in the three allosteric PFKs but not in LbPFK.  These twenty-two residues were
substituted for their counterpart from LbPFK, the proteins purified and characterized.
Using the strategy from Chapter III, we can introduce one of the mutations
identified from Chapter V, that resulted in diminished allosteric responses to MgADP and
PEP, into each of the four unique heterotropic interactions.  The effect this mutation has
on one or more of the heterotropic interactions in EcPFK with respect to PEP and
MgADP is addressed in Chapter VI.
This dissertation aims to define the basis for allosteric regulation in EcPFK by
determining which allosteric site is coupled to which active site and by probing the
differences between EcPFK and BsPFK, and LbPFK.  This work should enlighten us
onto the path and/or residues important for the transmission of allosteric information in
EcPFK.
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CHAPTER II
GENERAL METHODS
Materials and Methods
Materials.  All chemical reagents and buffers were analytical grade, purchased
from Fisher Scientific or Sigma-Aldrich.  The sodium salts of fructose-6-phosphate,
phospho(enol)pyruvate, NADH and phosphocreatine, and the potassium salt of ADP
were purchased from Sigma.  Creatine kinase, the ammonium sulfate suspensions of
aldolase, triose phosphate isomerase and glycerol-3-phosphate dehydrogenase, the
sodium salt of ATP and dithiothreitol were purchased from Roche Diagnostics.  Dye
Matrex Blue A resin and Mimetic Blue-1 resin for affinity chromatography were
purchased from Amicon and Prometic Biosciences, respectively.  Mono Q 10/10, an
anion exchange column, was purchased from Pharmacia for use on their Fast
Performance Liquid Chromatrography (FPLC) system.  DE-52 resin, an anion exchange
resin, was obtained from Whatman.  BCA protein assay reagents were purchased from
Pierce.  Glycerol stocks of BMH 71-18 mutS and XL1Blue cells were purchased from
Promega and Stratagene, respectively.  A glycerol stock of E. coli DF1020 cells (cells
deleted of PFK-1 and PFK-2 genes, Daldal, 1983) was obtained from Dr. Robert Kemp
(Chicago Medical School).  DNA oligonucleotides were ordered either from Gene
Technologies Laboratory (GTL) at Texas A&M University or Integrated DNA
Technologies, Inc (IDT).  Plasmid miniprep kit was purchased from Qiagen.  DNA
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sequencing was performed by GTL on Applied Biosystems 373XL and 377XL DNA
sequencers.
Site-directed Mutagenesis.  The Altered Sites II in vitro mutagenesis system
from Promega was primarily used to introduce site-specific substitutions in pGDR16
(Johnson et al, 2001).  This plasmid contains E. coli PFK-1 gene cloned into pAlter-1
from Promega and is used to express wildtype EcPFK and construct all mutants.  The
protocol from the Altered Sites system was followed to introduce single or multiple
mutations in pGDR16 (Figure 2-1).  Single-stranded pGDR16 was produced using R408
helper phage and purified.  Oligonucleotides that are complementary to the single-
stranded DNA containing the mutation(s) of interest and an oligonucleotide that repairs
the ampicillin resistance gene in the plasmid were annealed to the single stranded DNA.
The oligonucleotides were extended using T4 DNA polymerase and ligated with T4
DNA ligase.  The resulting plasmid was transformed into a mismatch repair minus strain
of E. coli (BMH 71-18 mut S) and grown on LB plates containing ampicillin.  Colonies
were inoculated into 5 mL LB-Amp overnight cultures, and the plasmid was purified
using Qiagen plasmid miniprep kit.  Because of the instability of BMH cells, the purified
plasmid was transformed into competent XL1Blue cells.  Plasmid was purified out of the
XL1Blue cells and sequenced using Sanger dideoxy method using dye-labeled
terminators and ABI sequenchers to confirm the sequence of the mutated DNA.
QuikChange Site-directed Mutagenesis system was used to introduce additional
mutations in pGDR16 (Figure 2-2).  Two oligonucleotides complementary to one
another containing the mutation(s) of interest were annealed to the denatured plasmid
29
1.  Clone insert into pALTER-1 vector.
2.  Isolate dsDNA.
3.  Prepare ssDNA and anneal mutagenic oligo(s),
Ampicillin Repair oligo and Tetracycline Knockout Oligo.
4.  Synthesize mutant strand with T4 DNA Polymerase
and T4 DNA Ligase.
5.  Transform competent BMH cells with mutagenesis
reaction. Grow overnight with ampicillin selection.
6.  Purify plasmid DNA and transform into XL1-Blue cells.
Select mutants on ampicillin plates.
Optional.  Perform additional rounds of mutagenesis
using selection for Tet repair alternating with Amp repair.
FIGURE 2-1:  Altered Sites II in vitro mutagenesis protocol from Promega.  This figure
was adapted from Promega.
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Parental DNA plasmid
Mutagenic primer
Mutated DNA plasmid
LEGEND
Gene in plasmid with target site (   ) for mutation
Denature the plasmid and anneal the oligonucleotide
primer (   ) containing the desired mutation (X)
Step 1: Plasmid Preparation
Step 2: Temperature Cycling
Step 3: Digestion
Step 4: Transformation
Using the non-strand displacing action of
PfuTurbo DNA polymerase, extend and incorporate
the mutagenic primers resulting in nicked circular strands
Digest the methylated, nonmutated parental
DNA template with DpnI
Transform the circular, nicked dsDNA into
Xl1-Blue competent cells
After transformation, the Xl1-Blue cells repair
the nicks in the mutated plasmid
Mutated plasmid
(contains nicked
circular strands)
FIGURE 2-2:  QuikChange site-directed mutagenesis protocol from Stratagene.  This
figure was adapted from Stratagene.
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and extended during temperature cycling by using PfuTurbo DNA polymerase and
treated with DpnI endonuclease that digests the nonmethylated parental DNA template.
The newly synthesized DNA was transformed into XL1Blue cells, the plasmid purified
and sequenced to verify the sequence of the mutant DNA.
Protein Purification.  The purification of wildtype or mutant PFK followed the
protocol of Johnson et al. (2001) with modifications.  DF1020 cells containing PFK in
pALTER1 were grown in 1.5 L LB broth containing 100 mg/ml ampicillin at 37°C for 24
hours.  Cells were harvested by centrifugation at 5000 x g using a Beckman Model J-6B
centrifuge.  Pelleted cells were stored at -20°C until ready for lysis.  The frozen cell
pellets were resuspended in approximately 30 mL of Buffer A (50 mM Tris-HCl pH 7.5,
5mM MgCl2, 0.1 mM EDTA, 2 mM DTT).  Cells were lysed by sonication using a Sonic
Dismembrator Model 550 (Fisher Scientific) with 15-second pulses for a total sonication
time of 8 minutes.  Crude lysate was cleared by centrifugation at 12,000 RPM for 1 hour
in a Beckman J2-21 centrifuge with a JA-20 rotor.  The supernatant was incubated in the
presence of DNase at 37°C for 15 minutes before centrifuging the remaining cell debris
away for another hour.  The final supernatant containing soluble proteins was applied to
a dye-affinity column that has been equilibrated with Buffer A.  Two dye-affinity resins
have been used and their elution procedures differ.  When using Dye Matrex Blue A
from Amicon, the column was washed with 100 mL each of Buffer A, Buffer A + 1.5 M
NaCl, and Buffer A + 2 mM ATP to elute off any loosely bound proteins.  With
subsequent re-use of the resin, the affinity the resin has for PFK decreased and PFK was
eluted when washed with Buffer A + 2 mM ATP.  The remaining PFK was eluted with
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Buffer A + 2 mM ATP + 1.5 M NaCl + 10 mM MgCl2.  Due to an apparent lower
affinity of Mimetic Blue for PFK than the Matrex Blue, when using the Mimetic Blue
resin from Prometic Biosciences, the final supernatant was diluted to 100 mL before
loading onto the column.  The column was then washed with 100 mL of Buffer A before
eluting PFK with Buffer A + 1.5 M NaCl and fractions collected.  Each fraction was
assayed for its absorbance at 280 nm and activity (Figure 2-3).  The fractions that have
enzymatic activity were pooled, concentrated using Amicon YM-10 concentrators and
dialyzed against Buffer A.  The purified protein was run on SDS-PAGE (Laemmli,
1970) to check for purity (Figure 2-4).  Most of the purified proteins after the Blue
column were at least 95% pure.  If there were multiple bands on the gel, the protein was
passed through anion-exchange chromatography, either a Mono Q column on Pharmacia
FPLC or a DE-52 column, and eluted with 0 to 1 M NaCl gradient.  Fractions were
collected and assayed (Figure 2-5). The fractions containing PFK were pooled, dialyzed
against Buffer A and stored at 4°C.  A representative purification table is shown Table 2-
1.
Enzymatic Activity.  Standard activity assays were performed at pH 8.0 and
25°C unless otherwise noted.  The production of fructose-1,6-bisphosphate, using a
coupled-enzyme system, was monitored by the oxidation of NADH (Figure 2-6).  The
reaction was started with the addition of 6 ml of PFK to a total volume of 600 ml of an
EPPS buffer containing 50 mM EPPS-KOH, 10 mM MgCl2, 10 mM NH4Cl, 0.1 mM
EDTA), 2 mM DTT, 250 mg aldolase, 50 mg glycerol-3-phosphate dehydrogenase, and 5
mg triose phosphate isomerase that was adjusted to pH 8.0.  F6P, MgATP and either PEP
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FIGURE 2-3:  Elution profile of PFK off Blue dye affinity column. A) Using Amicon
Matrex A resin, PFK was eluted off by ATP and ATP+NaCl.  B) Using Mimetic Blue
resin, PFK was eluted with 1.5M NaCl.  Activity and absorbance are represented by <
and =, respectively.  Fractions containing activity were pooled and dialyzed.
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1 2 3 4 5 6 7
FIGURE 2-4:  SDS-PAGE of purified PFK.  The first and the seventh lane contains
molecular weight ladder.  The second lane contains sample after the first centrifugation
step.  The third lane contains sample before loading onto the Blue A affinity column.
The fourth lane contains pooled fractions off the Blue affinity column.  The fifth lane
contains purified sample off DE-52, an anion-exchange column.  The sixth lane is a
control PFK sample.
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FIGURE 2-5:  Elution profile of PFK off an anion-exchange column.  PFK was eluted
off the DE-52 column with a gradient from 0 to 1 M NaCl.  Activity and absorbance are
represented by <  and = , respectively.  NaCl concencentrations are given by t.
Fractions containing activity were pooled and dialyzed.
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Creatine
Aldolase
Fructose-6-phosphate Fructose-1,6-bisphosphate
Dihydroxyacetone phosphate
Triose phosphate isomerase
Glycerol-3-phosphate dehydrogenase
NADH
NAD+
Glyceraldehyde-3-phosphate
Glycerol-3-phosphate
H+
Phosphofructokinase
MgATP MgADP
Creatine kinase
Phosphocreatine
FIGURE 2-6:  Coupling enzyme system.  Enzymatic activity of PFK is measured by
following product formation coupled to NADH oxidation.  Enzymes are in italics.
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or MgADP concentrations were varied as indicated.  For maximal activity, 3 mM ATP
and 5 mM F6P were added.  For assays at pH 6.0 and 7.0, MES-KOH and MOPS-KOH
buffers were used instead of EPPS-KOH, respectively.  In the absence of MgADP, 40
mg/ml creatine kinase and 4 mM phosphocreatine were added to convert MgADP
contamination from substrate stocks to MgATP (Johnson and Reinhart, 1992).  When
MgATP is the variable, solutions of equal concentrations of MgCl2 and ATP were added
to the cocktail.  When MgADP was added, it was added as a solution of equal
concentrations of MgADP and MgATP to prevent competition between MgATP and
MgADP in the active site (Johnson and Reinhart, 1994).  MgADP contamination in the
MgATP stock solution was measured enzymatically (Jaworek et al, 1974).  The rate of
the reaction is measured by the decrease of absorbance at 340 nm as a function of time
on a Beckman DU640 spectrophotometer.  This absorbance change is converted to
activity by the multiplication with a conversion factor that takes into account the
extinction coefficient of NADH, the two to one stoichiometry between NAD+ and
fructose-1,6-bisphosphate production, and the dilution of the enzyme.  One Unit of
enzyme activity is defined as the amount of enzyme needed to produce 1 mmole of
fructose-1,6-bisphosphate per minute.
Protein Concentration.  Determination of protein concentration was performed
using the Bicinchoninic Acid (BCA) Protein Assay from Pierce (Smith et al, 1985) or
calculated using the extinction coefficient of PFK of 0.6 mg-1 mL-1 at 280 nm (Kotlarz
and Buc, 1977).
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Data Analysis.  Data were fit to appropriate equations using the non-linear least
squares fitting analysis of Kaleidagraph 3.5 software (Synergy).  Enzymatic activity was
measured at increasing concentrations of one substrate and at a saturating concentration
of the other as indicated.  Data were fit to the Hill equation (Hill, 1910)
† 
v
ET
=
kcat[A]
n H
K0.5
n H + [A]n H
[2-1]
where v is the steady-state rate of turnover, ET is the total amount of enzyme active sites,
kcat is the turnover number, K0.5 is the concentration of substrate (A) that gives half-
maximal activity and nH is the Hill coefficient.  To study the effect PEP has on the
binding of substrate F6P, K0.5 values as a function of PEP concentration were determined
using equation 2-1 and fit to the following equation (Reinhart et al., 1989):
† 
K0.5 = Kia
o Kiy
o + [Y]
Kiy
o + Qay[Y]
È 
Î 
Í 
˘ 
˚ 
˙ [2-2]
where Y is PEP, Kia° and Kiy° are dissociation constants of F6P and PEP in the absence
of any other ligands, respectively.  Data were weighted to the errors obtained from the fit
to equation 2-1.  The effect PEP has on the binding of F6P is given by the coupling
constant Qay which has the following relationship (Reinhart, 1983):
† 
Qay =
Kia
o
Kia
• =
Kiy
o
Kiy
•
[2-3]
where Kia• and Kiy• are dissociation constants of F6P and PEP in the saturating presence
of the other ligand, respectively.  The smaller the value of Qay is, the greater the
inhibition.  The same experimental approach was taken to study MgADP (X) activation
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of F6P binding, with the replacement of X for Y.  The value of Qax is greater than 1
when there is activation.  Figure 2-7 shows data for wildtype EcPFK fit to equation 2-2.
The dissociation constants in the absence of any other ligands were determined to be
0.30 ± 0.01 mM for F6P, 0.30 ± 0.01 mM for PEP, and 0.048 ± 0.002 mM for MgADP.
The coupling constants, Qax and Qay are 11.1 ± 0.2 and 0.0083 ± 0.0001, respectively.
These data indicate the MgADP activates F6P binding by eleven-fold and PEP inhibits
F6P binding by 120-fold.
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FIGURE 2-7:  Allosteric effects on wildtype EcPFK.  The extent of PEP inhibition (A)
and MgADP activation (B) on F6P binding were determined at pH 8.0 and 25°C.  The
K0.5 for F6P, determined using rates that were fit to equation 2-1, as a function of PEP
and MgADP were plotted.  Lines represent fits to equation 2-2.  Errors are plotted but
appear smaller than the data points.  MgATP concentration was 3 mM.
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CHAPTER III
DISENTANGLING THE WEB OF MgADP ACTIVATION IN
PHOSPHOFRUCTOKINASE FROM ESCHERICHIA COLI
Introduction
Phosphofructokinase from E. coli is subject to allosteric regulation by MgADP
and phospho(enol)pyruvate (PEP).  These two effectors compete for binding at an
allosteric site that is remote from the substrate-binding site.  The enzyme can
discriminate between the two effectors and once bound, MgADP increases the binding
affinity for F6P to the active site whereas PEP decreases the binding affinity of F6P.
How this occurs within the enzyme is still an interesting question.
EcPFK is a homotetramer with four active sites and four allosteric sites that form
at subunit interfaces.  Each site is composed of two half sites from each monomer to
complete that site to which substrate or effector binds.  Because each binding site can
communicate with one another, there are twenty-eight possible pair-wise interactions
between binding sites (Figure 3-1A).  This allosteric web of potential interactions makes
the study of allosteric communication complicated.  This web of interactions can be
disentangled using mutagenesis and the hybrid tetramer approach (Kimmel and Reinhart,
2001; Fenton and Reinhart, 2002; Ortigosa et al, 2004) to isolate the four unique
heterotropic interactions in EcPFK shown in Figure 3-1B.  The study of each of the
single heterotropic interactions would help in the understanding of how allosteric
information is transmitted within the protein.
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30Å
45Å
23Å
33Å
FIGURE 3-1: The potential allosteric interactions found in EcPFK.  A) The allosteric
web of potential interactions.  There are twenty-eight interactions: twelve homotropic
interactions shown in the red lines between fructose-1,6-bisphosphate (red) in  the active
sites and in the blue lines between MgADP (blue) in the allosteric sites, and sixteen
heterotropic interactions as shown in the black lines. B) There are only four unique
heterotropic interactions, labeled by their spatial distances between sites from the crystal
structure determined by Shirakihara and Evans, 1988.
A B
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The focus of this chapter is the isolation using the hybrid tetramer approach and
characterization of two of the four unique heterotropic interactions with respect to their
allosteric responses to MgADP as compared to a control created for the wildtype enzyme
that is devoid of homotropic cooperativity in F6P binding (Fenton and Reinhart, 2002).
Hybrid tetramers have been created to study the effect PEP has on the four unique
heterotropic interactions within PFK from B. stearothermophilus (Kimmel and Reinhart,
2001; Ortigosa et al, 2004).  Each interaction is unique and their coupling free energies
for PEP inhibition sum up to the magnitude of the coupling free energy of a control
hybrid without homotropic cooperativity in PEP binding (Ortigosa et al, 2004).  Since
EcPFK and BsPFK have many similarities in sequence, structure and function, we are
interested to ascertain whether the allosteric communication pathways would also be
similar between the two enzymes.
Materials and Methods
Materials.  All chemical reagents used for protein purification and enzymatic
assays were obtained as described in Chapter II.  Potassium thiocyanate (KSCN) was
purchased from Sigma-Aldrich.  The following oligonucleotides were ordered from
Gene Technologies Laboratory (GTL) at Texas A&M University and DNA
Technologies Integrated (IDT):
K2,3E: CCG-CTT-GTC-AAC-ACA-CCG-ATT-TCC-TCA-ATC-ATG-ACT-ACC-
TCT-GAA-GC
R21A: CAG-CGC-AGA-ACG-AAC-AAC-CCC-AGC-AAT-TGC-GGC-GTT-CAT-
45
GCC-TGG
R154E: CTG-GTG-AGA-AGA-AGA-GGT-GTC-TTC-CAG-ACG-GTC-GAT-CGC-
TCC-TAC
K213E: GGT-AAT-CGC-CAC-GAT-CGC-GTG-TTT-TTC-ACC-TTT-CGC-GAT-
ACC-CGC
R252E: GGC-ACC-GGA-GAA-CCA-CCT-TCC-TGG-ATG-TGG-CCC-AGC
H249E coding: CTG-TGC-TGG-GCG-AAA-TCC-AGC-GCG-GTG-GTT-CTC-C
H249E noncoding: GGA-GAA-CCA-CCG-CGC-TGG-ATT-TCG-CCC-AGC-ACA-G
Methods.  Promega Altered Sites II in vitro mutagenesis system was used to
perform site-specific substitutions on pGDR16 (Johnson et al., 2001) using the
oligonucleotides ordered.  Constructs containing single-point mutations (R154E, K213E,
R252E and H249E) and constructs for the 30Å mutant (K2,3E, R21A, R252E) and the
33Å mutant (K2,3E, K213E, R252E) were created.  Stratagene QuikChange site-directed
mutagenesis system was used to replace H252E with H249E in the constructs.  Plasmid
DNA was isolated using Promega Wizard spin preps.  DNA was sequenced across the
modified sites to confirm the desired mutations.  The mutated plasmids were
transformed into DF1020 cells (Daldal, 1983).  Protein purification using the Amicon
Dye Matrex Blue A resin and kinetic assays were performed at pH 8.0 and 8.5°C as
described in Chapter II.
Hybrid Tetramer Formation.  The strategy shown in Figure 3-2 was used to
create hybrid tetramers.  The 30Å or the 33Å mutant (7 mg) was incubated with
wildtype EcPFK (3 mg) for 1.5 hours at 25°C with 0.4 M KSCN.  The denaturant was
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FIGURE 3-2: Strategy for creating hybrid tetramers.  In the presence of KSCN,
hybridization occurs between two parental proteins.  The species containing one unique
heterotropic interaction is boxed in red.  The 30Å and the 33Å interactions were isolated
using the 30Å mutant (K2,3E, R21A, H249E) and the 33Å mutant (K2,3E, K213E,
H249E), respectively as one of the parent proteins.
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dialyzed away at 4°C in Buffer A in the presence of 2 mM F6P for three hours to allow
for redistribution and creation of each hybrid species.  The protein mix was loaded onto
a 10/10 MonoQ anion-exchange column on Pharmacia FPLC and the species separated
by a shallow linear salt gradient from 0.23 to 0.3 M NaCl in Buffer A+2 mM F6P as
seen in Figure 3-3A.  This separation was facilitated by the presence of the mutations
K2,3E which act as surface-charge tags.  These mutations do not influence the kinetic
properties of the enzyme (Data not shown).  The identification and purity of each hybrid
species were assessed using 7.5% native polyacrylamide gel electrophoresis (Figure 3-
3B).  The hybrid species of interest is the 1:3 hybrid i.e., a tetramer with one wildtype
subunit and three mutated subunits.  This hybrid contains one native active site and one
native allosteric site capable of communicating with one another (a single heterotropic
interaction).  Subunit exchange of the 1:3 hybrid was prevented with the addition of F6P
to a final concentration of 20 mM immediately after elution off the MonoQ column.  The
same strategy was followed to create control hybrids that contain one active site and no
allosteric sites.  These controls check for the influence of the mutated allosteric sites on
the native active site.  They are formed by incubating R21A or K213E with the 30Å or
33Å mutant, respectively.
Data Analysis.  Data were fit to appropriate equations using the non-linear least
squares analysis of Kaleidagraph 3.5 software (Synergy).  Tetramers with sufficient
affinity for F6P to achieve saturation were fit to the Hill equation (Equation 1-9, 2-1).
For hybrids with a single active site, the linear region of the F6P titration curves were fit
to a form of the Michaelis-Menten equation (Lehninger et al, 1993):
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FIGURE 3-3: The purification of the hybrid tetramer containing the 33Å heterotropic
interaction.  A) Elution profile off the FPLC MonoQ column of the KSCN-treated
proteins.  The absorbance at 280 nm (ô) and activity (£) of each fraction were assayed.
Separation is facilitated by the presence of the surface mutations K2,3E.  B)
Identification and assessment of the purity of each hybrid species using 7.5% native
PAGE.  The 1:3 hybrid that contains one heterotropic interaction is shown in red.  The
purification of the 30Å interaction is similar.
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rate = Vmax
K0.5
Ê 
Ë 
Á 
ˆ 
¯ 
˜ [F6P] [3-1]
that arises with the assumptions that the substrate (F6P) concentrations are much smaller
than the concentration of F6P that would give one-half maximal activity (K0.5) and the
maximal activity (Vmax) is constant.  Parameters obtained from the fits to equation 2-1
(K0.5) or equation 3-1 (1/(V/K)) were subsequently fit to equation 2-2 to obtain the
values for the coupling constant Qax that measures the magnitude of MgADP activation
of F6P binding.  The larger the value of Qax is, the greater the activation.  This coupling
constant is related to the coupling free energy, DGax, by equation 1-8.  Allosteric
activation results in DGaxvalues less than zero.
The coupling constants determined for the 30Å and the 33Å interactions were
corrected for contributions from the mutated allosteric sites.  This correction was
accomplished by dividing the 1/(V/K) values obtained at each MgADP concentration for
each interaction by its respective control.  The corrected data were fit to equation 2-2.
Results and Discussion
The hybrid strategy allows for the creation and isolation of a hybrid tetramer
containing one unique heterotropic interaction between F6P and MgADP in
phosphofructokinase from E. coli (Fenton and Reinhart, 2002).  This 1:3 hybrid (one
wildtype subunit and three mutated subunits) contains a single native active site and a
single native allosteric site capable of interacting with one another, which is the
definition of a heterotropic interaction.  There are four possible unique heterotropic
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interactions in EcPFK, two of which are characterized in this study.
The secret behind this strategy lies in the ability to decrease the binding affinities
of F6P and MgADP to the active and allosteric sites by modifying residues from one
side of the binding site.  Because of the interfacial nature of the F6P binding site and the
allosteric site (Figure 3-4), mutating contact residues from each side of the binding site
could greatly diminish binding.  The binding affinities for F6P were significantly
reduced in R162E and R243E, which lie on one side of the active site (Fenton and
Reinhart, 2002).  On the other side, R252E and H249E both exhibit decreased binding
affinities for F6P by well over two orders of magnitude even without saturation, with
H249E showing a greater effect (Figure 3-5).  In the allosteric site, R21A has been
shown to disrupt the binding of MgADP.  Moreover, there was no apparent activation of
F6P binding by MgADP (Fenton and Reinhart, 2002).  On the other side of the allosteric
site, we have studied R154E and K213E.  Figure 3-6 shows that K213E does
substantially decrease MgADP binding or activation, unlike R154E.  Therefore, we find
that H249E or R252E in the active site and K213E in the allosteric site are sufficient for
decreasing the binding affinities of ligands to those sites.
Now that we have identified the contact residues that affect binding of F6P and
MgADP, we can create hybrid tetramers containing each of the four unique heterotropic
interactions as shown in Figure 3-7.  Table 3-1 shows four constructs that would isolate
their corresponding single heterotropic interactions when incubated with wildtype.
Surface charge-tags, K2,3E, were also introduced to allow for the purification of the 1:3
hybrid.  Incubating K2,3E, R21A, H249E with wildtype would create a 1:3 hybrid
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FIGURE 3-4: The interfacial nature of the binding sites in EcPFK as determined by
Shirakihara and Evans, 1988.  A) The active site.  Residues that make up the binding
pocket from two subunits are labeled in grey and purple.  Fructose-1,6-bisphosphate and
MgADP are labeled in red and blue, respectively.  B) The allosteric site.  Residues from
two subunits are labeled in pink and purple.  ADP is in blue.  Arrows show the residues
that have been mutated in this study.
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FIGURE 3-5: Specific activity measurements as a function of F6P for wildtype EcPFK
(°, left vertical axis), R252E (®, right vertical axis) and H249E (Ø, right vertical axis).
Lines represent best fits to equation 2-1 (wildtype) and equation 3-1 (R252E and
H249E).
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FIGURE 3-6: The influence of MgADP on wildtype (Å), R154E (£) and K213E (Ø).
Lines represent fits to equation 2-2.
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FIGURE 3-7: Schematic of the monomer (A) and the tetramer with each of the four
unique heterotropic interactions (B) in EcPFK.  The residues that were mutated to give
reduced binding affinities for substrate and effectors are labeled.  Depending on the
mutations used (shaded), each of the four heterotropic interactions can be created.
Surface-tags (K2,3E) were used to facilitate separation of hybrids.  The 23Å and the 45Å
interactions can be created using the active site mutation R243E (Fenton and Reinhart,
2002; Fenton et al., 2004).
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TABLE 3-1:  Constructs created containing mutations used to isolate the four
heterotropic interactions in EcPFK.
Construct Charge-tag Active site Allosteric site
33Å mutant K2,3E H249E K213E
30Å mutant K2,3E H249E R21A
23Å mutant* K2,3E R243E K213E
45Å mutant* K2,3E R243E R21A
* Created by Dr. Aron Fenton
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containing the 30Å heterotropic interaction.  The 33Å interaction can be formed by the
the hybridization between wildtype and K2,3E, K213E, H249E.  The 23Å and the 45Å
interactions contain R243E in the mutated active sites and K213E and R21A in the
mutated allosteric sites, respectively.
Control hybrids were also created for each heterotropic interaction to correct for
any activation that could arise from the binding of MgADP to the mutated allosteric
sites.  These 1:3 hybrids contain one native active site and no native allosteric sites, and
were created by mixing R21A or K213E instead of wildtype with their respective
constructs.  R252E instead of H249E as the active site mutation was used in two of the
control hybrids.  It does not matter which active site mutation is used as long as the
binding of F6P is reduced and since we are only concerned with the effect of MgADP
binding to the mutated allosteric sites.  Figure 3-8 shows the effect of the 30Å and the
33Å control hybrids on MgADP activation.  The Qax values for both controls were very
close to one, indicating that there is little to no effect arising from either R21A or K213E
mutated allosteric sites (Fenton et al., 2004).
Each of the four heterotropic interactions were isolated and characterized for the
affect of MgADP activation (Fenton and Reinhart, 2002, Fenton and Reinhart, 2004).
Activation by MgADP on the 30Å and the 33Å interactions is shown in Figure 3-9 with
a two-fold enhanced activation in 33Å interaction as compared to that of the 30Å
interaction after correcting for the effect of MgADP on the R21A and K213E mutated
sites.  The coupling constants and coupling free energies obtained for these heterotropic
interactions, however, cannot be compared to that of wildtype since there is positive
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FIGURE 3-8: Controls used in this study.  These controls contain one intact active site
and no intact allosteric sites.  A) Schematic of the two controls.  B) The influence the
mutated allosteric sites have on the one intact active site can be measured for the 30Å
(ô) and the 33Å(£ ) interactions.  The Qax values for both controls are near one,
indicating that there is little to no effect arising from either R21A or K213E mutated
allosteric sites.
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FIGURE 3-9: The influence of MgADP on the 30Å (ô ) and 33Å (£) interactions
shown in Figure 3-7.  These interactions have been corrected for the influence the
mutated sites have on the native active site from Figure 3-8 by dividing the 1/(V/K)
values obtained at each MgADP concentration for each interaction by its respective
control.  The lines represent best fits to equation 2-2.  Errors are plotted on the points but
are too small to be seen.the 1|4 control was created to eliminate this cooperativity
(Fenton and Reinhart, 2002).  This control contains one native active site and four native
allosteric sites, thereby having all four heterotropic interactions without homotropic
interactions.
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cooperativity in F6P binding which was eliminated in the hybrids.  Therefore, the 1|4
control, which contains one native active site capable of communicating with four native
allosteric sites, was created to eliminate positive cooperativity in F6P binding in EcPFK
(Fenton and Reinhart, 2002).
Table 3-2 and Figure 3-10 compare all the four unique heterotropic interactions
with the 1|4 control, with the 33Å interaction contributing the largest percentage (36%)
of total activation in the 1|4 control.  The 30Å, the 23Å and the 45Å interaction
contributes 23%, 25% and 20% of the total activation, respectively.  Each individual
interaction has a unique magnitude and the sum of all the four interactions is 104±4%,
thereby accounting for all the couplings in the 1|4 control.
Conclusions
The dissection of the web of potential allosteric interactions has been
successfully performed using the hybrid tetramer approach to study the effect of
MgADP activation on the four unique heterotropic interactions within EcPFK.  Contact
residues that are important for the binding of F6P and MgADP have been determined for
each side of the binding sites.  R252E and more importantly H249E decreased the
binding of F6P substantially on one side of the active site.  K213E shows a decrease in
MgADP binding and activation by MgADP on one side of the allsoteric site.  The
important residues from the other sides of the active and allosteric sites have already
been determined (Fenton and Reinhart, 2002).
The 30Å and the 33Å heterotropic interactions were assessed for the effect of
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TABLE 3-2: Thermodynamic parameters for the four unique heterotropic interactions at
8.5°C and pH 8.0.
Construct Qaxa DGax (kcal/mol)b % Contributionc
Wildtype EcPFK 14.4 ± 0.4 -1.49 ± 0.02 ------
1|4 controld 155 ± 6 -2.87 ± 0.02 100
30Å interaction 3.0 ± 0.2 -0.62 ± 0.03 23 ± 1
33Å interaction 6.4 ± 0.2 -1.04 ± 0.02 36 ± 1
23Å interaction 3.6 ± 0.2 -0.73 ± 0.04 25 ± 1
45Å interaction 2.8 ± 0.1 -0.58 ± 0.01 20 ± 1
aQax are obtained from the fits to equation 2-2 and are corrected for the effects from the
mutated allosteric sites.
bDGax, the coupling free energy, was calculated using the equation: DGax= -RTlnQax.
c%Contribution of each interaction with respect to DGax determined for the 1|4 control
(Fenton and Reinhart, 2002; Fenton et al., 2004)
d1|4 control, containing one intact active site and four intact allosteric sites, eliminates
homotropic cooperativity of F6P binding to EcPFK (Fenton and Reinhart, 2002).
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FIGURE 3-10: Percent coupling free energies for MgADP activation for the four unique
heterotropic interactions in EcPFK.  Data for the 23Å and the 45Å interaction were
obtained by Dr. Aron Fenton (Fenton et al., 2004).  Each interaction was compared to
the heterotropic coupling exhibited by the 1|4 control (Fenton and Reinhart, 2002). The
sum of all the four interactions are 104±4%, thereby accounting for all the couplings in
the 1|4 control.
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MgADP activation, with a two-fold greater activation observed in the 33Å compared to
the 30Å interaction.  The 23Å and the 45Å interactions were also studied (Fenton and
Reinhart, 2002, Fenton et al., 2004).  When each interaction was compared to the 1|4
control, which has homotropic cooperativity of F6P binding eliminated, we conclude
that each heterotropic interaction is unique and adds up to 104±4% of the 1|4 control.
These results suggest that the allosteric activation of EcPFK cannot be
adequately interpreted by the popular two-state models.  The sequential model
(Koshland et al, 1966) predicts that only one interaction would dominate substantially,
whereas the concerted model (Monod et al., 1965) predicts that each interaction should
produce 100% of the allosteric effect.  Since each of the heterotopic interactions is
unique and they are additive, our observations do not support these predictions.
A comparative study of the effects of MgADP and PEP on the four unique
heterotropic interactions can be performed on EcPFK and BsPFK.  The pattern of
percent contributions of each of the heterotropic interactions found for MgADP
activation in EcPFK is different from that for PEP inhibition in BsPFK.  In BsPFK, the
largest percentage was observed in the 23Å interaction with very little allosteric
inhibition in the 45Å interaction (Ortigosa et al., 2004).  These data suggest that PEP
inhibition and MgADP activation use different communication pathways as previously
suggested by Fenton et al., 2003.  This could also mean that these differences are
specific to the particular isozymes.
Finally, we can infer that the mutations used to create the hybrids themselves did
not introduce any perturbations to the individual couplings since they are all accounted
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for in the 1|4 control and that MgADP homotropic interactions are not present.
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CHAPTER IV
INVESTIGATION INTO THE STRUCTURE-FUNCTION
RELATIONSHIP OF PHOSPHOFRUCTOKINASE FROM
LACTOBACILLUS BULGARICUS
Introduction
Interest in understanding the molecular basis of allostery brought us to study
bacterial phosphofructokinases. Phosphofructokinase (PFK) catalyzes the first
irreversible step in the glycolytic pathway.  Bacterial PFKs respond to changing levels of
MgADP and phospho(enol)pyruvate (PEP) (Blangy et al, 1968, Uyeda, 1979, Tlapak-
Simmons and Reinhart, 1998, Johnson and Reinhart, 1994, 1997).  These molecules
compete for binding to the same allosteric site in the enzyme with different effects.
MgADP activates PFK by increasing the binding affinity for F6P in the active site while
PEP inhibits the binding of F6P.  The means by which the enzyme can differentiate
which molecule is bound and respond appropriately remains a compelling question.
Phosphofructokinases from Escherichia coli (EcPFK) and B a c i l l u s
stearothermophilus (BsPFK) are two of the most extensively characterized bacterial
PFKs.  Investigations into their allosteric properties and structures have been performed
to understand the basis for allosteric regulation (Deville-Bonne et al, 1991, Tlapak-
Simmons and Reinhart, 1998).  The crystal structures of these enzymes have been solved
and they show a high degree of similarity to one another (Evans et al, 1981; Shirakihara
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and Evans, 1988).
Phosphofructokinase from Lactobacillus delbrueckii subspecies bulgaricus
(LbPFK) contains 47% identity and 66% similarity to EcPFK, and 56% identity and
74% similarity to BsPFK.  Interestingly, LbPFK has been reported to be unresponsive to
allosteric ligands at pH 8.2 (Le Bras et al., 1991).  According to that study, the maximal
activity of the enzyme is influenced by pH.  The activity of LbPFK was inhibited by the
presence of 8mM and 20mM PEP at low pH values.  MgGDP or MgADP binding to
LbPFK was not observed and thereby no activation.  From these data, Le Bras et al.
concluded that LbPFK is a non-allosteric enzyme.
The study presented here describes a more thorough investigation into the kinetic
properties of PFK from L. bulgaricus using a linked-function approach (Reinhart, 1983,
1988).  In addition, we present the crystal structure of LbPFK, determined to 1.86Å
resolution, to allow analysis of the three-dimensional structural features of this enzyme.
A comparative analysis of the structure and function relationship between the non-
allosteric LbPFK to the extensively studied PFKs from E. coli and B. stearothermophilus
may facilitate our understanding of the allosteric response mechanisms of these
enzymes.
Materials and Methods
Materials. PFK from L. bulgaricus B107, cloned into pKK223-3, was kindly
provided by Danone Vitapole SA, France (Branny et al., 1993).  All chemical reagents
used in protein purification and enzymatic assays were obtained as mentioned in Chapter
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II.  Optimize solutions and crystallization materials were purchased from Hampton
Research.
M e t h o d s .   pKK223-3/PFK was transformed into DF1020 cells for
overexpression of the PFK gene in a PFK minus strain (Daldal, 1983).  Cells were grown
up in 3 L LB broth in the presence of 0.1 mg/mL ampicillin, harvested after 24 hours,
and stored at -20°C.  Purification of PFK from L. bulgaricus was similar to that of E.
coli, with a few modifications.  DF1020 cells were resuspended in a lower ionic strength
buffer (10 mM Tris-HCl pH 7.2, 0.1 mM EDTA) before lysis and centrifugation.  After
DNase treatment and centrifugation, the crude lysate with loaded onto a pre-equilibrated
Mimetic Blue-1 resin.  PFK was eluted with a gradient of 0 to 2 M NaCl in the same
buffer.  Fractions containing PFK were pooled, dialyzed against Buffer A and
concentrated.  Purity was assessed by SDS-PAGE.  The purity of LbPFK at this point
was sufficient for kinetic characterization, however, an additional purification step was
required for crystallization trials.  The concentrated protein was loaded onto a pre-
equilibrated DE-52 anion exchange column.   PFK was then eluted from the anion-
exchange column with a 0 to 1 M NaCl gradient in Buffer A.  Fractions containing PFK
were pooled, dialyzed against Buffer A, concentrated and stored at 4°C.  The Pierce
BCA protein assay was used to determine protein concentrations.
Standard PFK activity assays were performed at pH 8.0 and 25°C, unless
otherwise noted.  Activity assays were performed as described in Chapter II.  However,
15 mM MgATP was used instead of 3 mM for maximal activity.  For pH studies, MES-
KOH and MOPS-KOH buffers were used for pH 6 and pH 7, respectively.
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Data Analysis.  Data were fit to appropriate equations using the non-linear least
squares fitting analysis of Kaleidagraph software (Synergy).  The binding affinities for
substrate F6P and MgATP were obtained by fitting to equation 2-1.  In the presence of
substrate inhibition, data were fit to the following equation (Cleland, 1986):
† 
v
ET
=
kcat[A]
K0.5 + [A]+ [A]
2 /Ki
[4-1]
where Ki is the inhibition constant.  To quantify the allosteric responses of PFK to
MgADP or PEP, parameters obtained from the fit to equation 2-1 were further fit to the
equation 2-2.  For LbPFK where effector binding is very weak and allosteric saturation
could not be obtained, data were fit to the competitive inhibition equation (Cleland,
1986):
† 
K0.5 = K0.5
o 1+ [X]
Ki
Ê 
Ë 
Á 
ˆ 
¯ 
˜ [4-2]
where Ki is the inhibition constant or the dissociation constant of effector X.
Crystallization and Data Collection.  PFK from L. bulgaricus was crystallized
at 18°C using the hanging drop vapor diffusion method with 4 mL handing droplet
consisting of a 1:1 mixture of the stock protein solution and the reservoir solution (0.1 M
Tris-HCl pH 7.5, 1 mM DTT, at 0.1 M increments of 0.8 M to 1.4 M ammonium
sulfate). Within 48 hours, PFK crystals were observed in all wells and were hexagonal in
shape.  Crystals, grown in 1.2 M ammonium sulfate, were flash frozen at 100K using
20% ethylene glycol as cryoprotectant and X-ray diffraction data was collected at the
Advanced Photon Source (APS) beamline in Chicago.  Diffraction data was processed
and analyzed using HKL2000 programs (Otwinowski and Minor, 1997).
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Structure Determination, Modeling Building and Refinement.  Molecular
replacement program AMoRe (Collaborative Computational Project, 1994) was used to
solve the structure of LbPFK using PFK structure of Bacillus stearothermophilus
(Schirmer and Evans, 1990) as a model.  A clear solution with correlation coefficient of
42.9% was obtained from AMoRe. Iterative cycles of model building with XtalView
(McRee, 1999) using the ARPwARP improved phases figure of merit weighted 2|Fo|-
|Fc| maps (Perrakis et al., 2001) and refinement with REFMAC (Collaborative
Computational Project, 1994) were performed for improving the quality of the model.
Water molecules were added in the difference electron density maps at positions
corresponding to peaks (>3.0s) and with appropriate hydrogen bonding geometry.
Results and Discussion
PFK from L. bulgaricus was purified to homogeneity as assessed by SDS-PAGE
using affinity and anion-exchange chromatography (Figure 4-1 and 4-2).  Saturating
concentrations of MgATP and F6P were determined to obtain the maximal specific
activity of this enzyme at pH 8.0 and 25°C.  The dissociation constant for MgATP is
0.35±0.01 mM at high (5 mM) concentrations of F6P and the saturating concentration of
MgATP is at least 15 mM (Figure 4-3).  Substrate inhibition was observed for MgATP
binding under low concentrations of F6P.  This inhibition is also observed in PFK from
E. coli that is attributed to an allosteric antagonism between substrates (Fenton and
Reinhart, 2003).  To alleviate this inhibition, a saturating concentration of MgATP (15
mM) was used in all assays for maximal activity.  The binding of F6P to LbPFK is
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FIGURE 4-1: Purification of PFK from L. bulgaricus using affinity chromatography. A)
Elution profile of PFK off the Mimetic Blue-1 column.  The absorbance at 280 nm (n)
and activity (l) were measured for fractions eluted with increasing salt concentrations
(u). B) Assessment of purity by SDS-PAGE. Lane 1 is a known PFK standard, lane 2 is
crude lysate after sonication and centrifugation, lane 3 is supernatant after Dnase
treatment, lane 4 to lane 10 corresponds to fractions 15 to 23. Fractions 17-26 were
pooled and the salt dialyzed away.
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FIGURE 4-2: Purification of PFK from L. bulgaricus using anion-exchange
chromatography. a) Elution profile off the DE-52 column.  The absorbance at 280 nm
(n) and activity (l) are measured for fractions eluted with increasing salt concentrations
(u).  b) SDS-PAGE of protein fractions.  Lane 1 is a known PFK standard, lane 2 is the
pooled sample after Blue column, lanes 3 to 10 corresponds to fractions 10 to 19.
Fractions 14-17 off the DE52 column were pooled and the salt dialyzed away.
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FIGURE 4-3: Kinetic characterization of LbPFK as a function of MgATP in the
presence of 0.02 mM (ô), 5 mM (£) and 10 mM (Ø) F6P concentrations.  Data for
0.02 mM F6P was fit to equation 4-1, while the others were fit to equation 2-1.
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hyperbolic.  At saturating MgATP concentrations, F6P binding is pH dependent (Figure
4-4).  The dissociation constants for F6P are 0.060 ± 0.003mM, 0.030 ± 0.001mM and
0.020 ± 0.005 at pH 6, 7 and 8, respectively.  The saturating concentration of F6P is 1
mM in the presence of 15 mM MgATP.  The specific activity of LbPFK is 230±10 U/mg
at saturating concentrations of both substrates and is pH independent at 25°C.  This
specific activity is more than two-fold higher than that obtained by Le Bras et al., which
was probably due to the presence of monovalent cation, NH4+, that was included in our
assaying buffer.  Moreover, the concentration used by Le Bras et al. (2 mM) is not
enough to saturate the enzyme with MgATP, thereby lowering the apparent maximal
specific activity.
Allosteric Properties.  We observe weak binding of PEP to the enzyme that is
pH independent (Table 4-1).  However, the extent of inhibition cannot be determined
because of the inability to saturate the allosteric effect.  Inhibition of F6P binding by
PEP to LbPFK at pH 8 was only observed at high concentrations of PEP (Figure 4-5A).
Decreasing the pH to 6 or 7 does not seem to change the extent of PEP inhibition (Data
not shown).  MgADP binding to the enzyme is weak and slightly inhibitory (Figure 4-
5B).  The extent of MgADP inhibition also cannot be determined due to experimental
limitations and weak binding.  To confirm that MgADP does bind to the enzyme, PEP
inhibition was examined in the presence of two concentrations of MgADP.  Competition
between MgADP and PEP in the allosteric site was observed as the binding affinity for
PEP weakens in the presence of MgADP (Figure 4-6). This suggests that MgADP does
bind to the allosteric site though very weakly.  Dissociation constants derived from data
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FIGURE 4-4: pH dependence of F6P binding in LbPFK at saturating MgATP.  Activity
was measured as a function of F6P concentration at pH 6 (ô), pH 7 (£) and pH 8 (Ø).
Lines represent best fits to equation 2-1 and the resulting parameters are listed in Table
4-1.
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TABLE 4-1: Summary of kinetic parameters for EcPFK, BsPFK and LbPFK at 25°C.  X
and Y are MgADP and PEP, respectively.
Kiao (mM) Kixo (mM) Kiyo (mM) Qax Qay
EcPFK1 0.30±0.01 0.048±0.002 0.30±0.01 11.1±0.2 0.0080±0.0003
BsPFK2
pH 6 0.024±0.002 0.017±0.001 0.035±0.002 1.3±0.1 0.022±0.001
pH 7 0.027±0.001 0.019±0.002 0.051±0.008 1.7±0.1 0.0030±0.0001
pH 8 0.031±0.002 0.019±0.002 0.093±0.006 1.7±0.1 0.0021±0.0003
LbPFK3
pH 6 0.060±0.003 15±3 30±3 N. D. N. D.
pH 7 0.030±0.001 46±25 16±1 N. D. N. D.
pH 8 0.020±0.005 28±8 24±2 N. D. N. D.
1  EcPFK is pH independent (Deville-Bonne et al, 1991)
2  Data from Tlapak-Simmons and Reinhart, 1998
3  Data fit to equation 4-2
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FIGURE 4-5: The effect of allosteric effectors on EcPFK (ô), BsPFK (£) and LbPFK
(Ø) at pH 8 and 25°C.  A) The influence of PEP on F6P binding.  B) The influence of
MgADP on F6P binding.  Lines represent best fits to equation 2-2 for EcPFK and
BsPFK, and to equation 4-2 for LbPFK.
A
B
76
0.1
1
10
0 0.01 0.1 1 10 100
K
0.
5/K
0.
5 
(0
 P
EP
)
[PEP](mM)
FIGURE 4-6: Competition between MgADP and PEP for the allosteric site in LbPFK.
The effect of PEP inhibition in LbPFK was studied in the absence of MgADP (ô),
10mM MgADP (£) and 20mM MgADP (Ø).  Data were fit to equation 4-2 to obtain
the binding constants for PEP of 24±2 mM in the absence of MgADP, 47±9 mM in the
presence of 10mM MgADP and 56±4 mM in the presence of 20mM MgADP.
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for LbPFK can be compared to those obtained for EcPFK and BsPFK as shown in Table
4-1.  LbPFK and BsPFK both bind F6P with similar affinities.  The dissociation
constants of LbPFK for PEP and MgADP (~20mM) are much weaker than that of either
EcPFK or BsPFK.  The errors for the dissociation constants for LbPFK are somewhat
large because of the experimental limitations and thereby few data points at high effector
concentrations to get a good fit to equation 4-2.
Structure Determination and Overall Structure.  The crystals of PFK from L.
bulgaricus belong to space group P6222 with unit cell dimensions of a=135.0 Å and
c=77.7 Å, one monomer per asymmetric unit, and a solvent content of 58.7 %.  The
structure was determined by molecular replacement with B. stearothermophilus
phosphofructokinase model (PDB ID: 6PFK, Schirmer and Evans, 1990).  The final
structure, including all the 319 residues, two sulfate molecules and 252 water molecules,
refined at 1.85Å resolution, has a crystallographic R-value of 22.2% and an Rfree of
25.1%.  The details of the final refinement parameter are presented in Table 4-2.
The 319 residues in the LbPFK molecule form two structural domains, both with
3-layered aba sandwich structures.  The overall structure of the enzyme is very similar
to that of EcPFK (Rypniewski and Evans, 1989; Shirakihara and Evans, 1988) and
BsPFK (Evans et al., 1981; Evans and Hudson, 1979; Schirmer and Evans, 1990) as
shown in Figure 4-7.  Although there is only one molecule in the asymmetric unit, there
exists a 222 symmetry in the space group P6222, suggesting that the oligomeric state of
LbPFK is still tetramer and with 222 symmetry, very much like that of EcPFK
(Rypniewski and Evans, 1989; Shirakihara and Evans, 1988) and BsPFK (Evans et al,
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TABLE 4-2: Statistics from the crystallographic analysis.  Details of the crystallization
and structure determination see text. Rsym = ÂhÂi|Ih,I - Ih| |  ÂhÂiIh,I for the intensity (I) of
i observations of reflection h. R-factor = Â|Fobs-Fcalc| | Â|Fobs|, where Fobs and Fcalc are
the observed and calculated structure factors, respectively.  R-free = R-factor calculated
by using a subset (~5%) of reflection data chosen ramdomly and omitted throughout
refinement.  rmsd, root-mean-square deviations from ideal geometry.
Data set Native
Wavelength (Å)
Resolution (Å)
Measured reflections
Unique reflections
Redundancy
Completeness (%, highest shell)
Mean I/sI (highest shell)
Rsym (%, highest shell)
1.0419
1.86
560384
35567
15.8
98.5 (92.8)
50.6 (1.8)
5.7 (69.8)
Refinement
Resolution (Å)
No. of reflections |F|>0 sF
R-factor/R-free (%)
No. of non-H Atoms
No. of Sulfate molecules
No. of Solvent Atoms
rmsd bond lengths (Å)
rmsd bond angles (°)
Ramachandran plot (%)
Most favoured regions
Additional allowed regions
Generously allowed regions
Disallowed regions
20.0-1.85
33708
22.4 / 25.6
2649
2
259
0.009
1.1
92.6
6.7
0.0
0.7
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FIGURE 4-7: Comparison of the overall fold of LbPFK to the structures of EcPFK and
BsPFK. A) Superimposition of LbPFK (gold) with four BsPFK structures: the structure
of a mutant with F6P bound (1MTO.pdb) shown in red, with phosphate bound
(3PFK.pdb) in green, with F6P and MgADP bound (4PFK.pdb) in blue and with
inhibitor-analog phosphoglycolate bound (6PFK.pdb) in purple. B) Superimposition of
LbPFK (gold) with two EcPFK structures: with products bound (1PFK.pdb) in red and
unliganded (2PFK.pdb) in green.
A B
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1981; Evans and Hudson, 1979; Schirmer and Evans, 1990).  The root-mean-square
deviation (RMSD) between LbPFK and the active R-state BsPFK (PDB ID: 3PFK and
4PFK, (Evans et al., 1981; Evans and Hudson, 1979) is 0.81 ± 0.01 Å for 319 Ca atoms,
whereas that between LbPFK and the inhibited T-state BsPFK (PDB ID: 6PFK,
(Schirmer and Evans, 1990) is 1.23 ± 0.03 Å for 319 Ca atoms.  Further superimposition
analysis on the tetramer shows that the RMSD between LbPFK tetramer and the active
R-state BsPFK (PDB ID: 3PFK and 4PFK, (Evans et al., 1981; Evans and Hudson,
1979) tetramer is 0.90 Å for 1276 Ca atoms, whereas that between LbPFK tetramer and
the inhibited T-state BsPFK (PDB ID: 6PFK, (Schirmer and Evans, 1990) is 1.66 Å for
1276 Ca atoms, suggesting that the overall structure of LbPFK seems to correspond to
the active R-state.
Binding Sites.  Three binding sites have been reported in PFK structure, for
substrate pair F6P and MgATP in the active site, for activator MgADP or inhibitor-
analog phosphoglycolate (PGA) in the allosteric site (Evans and Hudson, 1979).  In the
LbPFK crystal structure, two inorganic sulfate ions from the crystallization condition
were located, similar to the bound inorganic phosphate ions reported in BsPFK structure
(Evans and Hudson, 1979).  One sulfate is bound in the active site, in correspondence
with the 6-phosphate group of F6P, the other one is bound in the allosteric site, in
correspondence with the b-phosphate group of ADP or the phosphate group of PEP.
The Active Site.  Based on the bound sulfates in LbPFK structure, and the
available co-crystal structures of both BsPFK and EcPFK, we built the models of F6P
and ADP in the active site, ADP or PGA in the allosteric site.  The active site, lying
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between the two domains of LbPFK subunit, is well conserved for both F6P and ATP.
The F6P binding site is mainly formed in the small domain of LbPFK (Figure 4-8A).
All residues involved in F6P binding are strictly conserved in LbPFK.  These include
Arg162, Arg243, His249 and Arg252 interacting with the 6-phosphate group of F6P,
Asp127, Met169 and Glu222 interacting with the sugar group of F6P.  The bound
inorganic sulfate forms salt bridges with His249 and Arg252 from one subunit, Arg162
and Arg243 from the other subunit, presumably stabilizing the LbPFK conformation to
the active R-state.  The ATP binding site is well conserved in the large domain of
LbPFK (Figure 4-8B).  Two signature glycine residues (Gly104 and Gly108), which
make space for the ATP, and Arg72, which interacts with the a-phosphate of the ATP,
are strictly conserved.  The side chains of Ala77, His107, Phe41 and Phe76, also
conserved, still form a non-specific hydrophobic slot for the adenine ring of ATP.
The Allosteric Site.  The allosteric site is where there are most obvious
differences (Figure 4-9).  Studies in EcPFK (Shirakihara and Evans, 1988) showed that
the main interactions between PFK and activator MgADP are with the phosphate groups
and the magnesium ion.  The magnesium ion forms octahedral co-ordination with the a
and b phosphate groups of ADP, the carbonyl oxygen of Gly185, the carboxyl of Glu187
and two water molecules (Shirakihara and Evans, 1988).  Glu187 is with special interest
since it is the only residue that shows major differences with different ligands (activator
or inhibitor) bound in the allosteric site.  In the active R-state, the side chain of Glu187
adopts a folded conformation, ready to be coordinated to the magnesium ion of ADP.  In
the inhibited T-state, the side chain c1 torsion angle of Glu187 changes by
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FIGURE 4-8: The active site of LbPFK. A) The F6P binding site of LbPFK with F6P
modeled in the site. B) The ATP binding site of LbPFK with ADP modeled in the
structure.  Residues interacting with F6P and ADP are labeled.
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G108
H107
F41
R72
F76
A77
R171
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FIGURE 4-9: Comparison of the allosteric sites of PFK with different ligands present.
A) MgADP-bound EcPFK. B) Phosphoglycolate-bound BsPFK. C) Sulfate-bound
LbPFK.
A B C
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~140°, rotating away from the ligand.  The new adopted position of the Glu187 side
chain pushes the side chain of Leu205 to change its conformation.  Glu187 was indicated
to be important for allosteric responsiveness in EcPFK (Auzat et al., 1994; Lau and
Fersht, 1987; Lau and Fersht, 1989). When substituted with an alanine at that position,
PEP actually activates F6P binding, whereas MgADP has no effect on F6P binding
(Pham et al. 2001).  Aspartic residue is present at position 187 in LbPFK.  The
octahedral co-ordination between the carboxyl of Asp187 and the magnesium might be
very weak or no longer exists.  In addition, there are fewer residues involved in the
interactions with the phosphate groups of ADP, which include Arg21, Arg25, Arg54,
Arg154 and Lys213 in EcPFK (Shirakihara and Evans, 1988) or Arg21, Arg25, Arg154,
Arg211 and Lys213 in BsPFK (Evans et al., 1981). Arg21, Arg25, Arg154 and Lys213
are conserved in LbPFK, whereas the corresponding residues for Arg54 and Arg211 are
Ser54 and Ser211 in LbPFK.  Furthermore, Asp59 in EcPFK and BsPFK forms
hydrogen bond with the ribose O3.  A histidine residue is present at position 59 in
LbPFK, which might break the interaction, further decreasing the affinity between
LbPFK and ADP in allosteric site.  There are still more differences that include Glu55
and Asp214.  The effect is not clear.
Conclusions
Our kinetic characterization of phosphofructokinase from L. bulgaricus reveals
an enzyme that binds substrates MgATP and F6P with dissociation constants of
0.35±0.01 mM and 0.020±0.001 mM, respectively and with a maximal specific activity
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of 230±10 U/mg at pH 8.0 at 25°C.  These numbers are different than those obtained by
Le Bras et al., which is probably due to the presence of divalent cation NH4 and a
saturating MgATP concentration in our assays. When compared to EcPFK, F6P and
MgATP binds to LbPFK with an order of magnitude tighter and weaker than to EcPFK,
respectively (Johnson and Reinhart, 1994).  On the other hand when compared to
BsPFK, the dissociation constant for F6P is similar, with the dissociation constant for
MgATP less than an order of magnitude weaker in LbPFK (Brynes et al., 1994; Riley-
Lovingshimer and Reinhart, 2001).  The specific activity of LbPFK is in between that of
EcPFK and BsPFK (Valdez et al, 1989).
No pH dependence was observed for this enzyme, except for F6P binding, which
also contradicts the observations made by Le Bras et al.  There was no pH dependence
on the maximal activity of LbPFK and no pH dependence on the effect PEP has on this
enzyme.  We observe weak binding (~20mM) of PEP and MgADP to LbPFK, which
seems to also be pH independent.  PEP inhibition is observed at pH 6, 7 and 8, unlike
their conclusion that PEP inhibition is only observed at pH 6 and not at pH 8.2.
Unfortunately, we cannot determine the extent of PEP inhibition.  MgADP activation is
not observed, however, MgADP inhibition seems to be present.  These affinities are
much lower than that for EcPFK and BsPFK (Table 4-1).
The crystal structure of LbPFK was solved to 1.86Å resolution.  The overall fold
is conserved between EcPFK, BsPFK and LbPFK.  The active site of LbPFK remains
intact, whereas the allosteric site is where the most differences lie within the structures
of EcPFK, BsPFK and LbPFK.  The tight binding of F6P to LbPFK is similar to that of
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BsPFK, which supports the active sites of both enzymes being similar.  The weak
binding of MgADP and PEP observed for LbPFK likely can be explained by the
differences in the allosteric site.  However, the structure does not provide a clear answer
to why the effects of MgADP and PEP on F6P binding are both inhibitory in LbPFK.
More experiments need to be performed to address this issue.
Nature must have created an enzyme whose binding site is not amenable to the
binding of allosteric effectors for a reason.  The binding affinities for MgADP and PEP
to LbPFK are very weak (~20 mM) and may be too weak to be physiologically
significant.  In contrast to Le Bras et al., we can conclude that at high concentrations of
effectors, there is PEP inhibition of F6P binding at pH 8.0 in LbPFK though not to the
same extent as that to EcPFK and BsPFK.  MgADP, on the other hand, shows slight
inhibition of F6P binding, unlike that to EcPFK and BsPFK.
Two other phosphofructokinases in the Lactobacillus family (Lactobacillus casei
and Lactobacillus plantarum) are reported to be unresponsive to allosteric ligands
(Doelle, 1972).  Extensive characterization of these enzymes need to be conducted to
study the binding and allosteric properties with regards to these effectors.  If indeed the
binding of allosteric effectors is also weak, we can hypothesize that PFK does not want
to function as an allosteric enzyme in lactobacilli at physiological conditions.
87
CHAPTER V
IDENTIFICATION OF RESIDUES IMPORTANT FOR
CONFERRING ALLOSTERY IN PHOSPHOFRUCTOKINASE
FROM ESCHERICHIA COLI
Introduction
Due to the rapid and intensive move towards the genomics era, the partial or
complete sequences of genomes of many organisms have been determined, published
and annotated.  Of the known sequences of phosphofructokinases (PFKs) from these
organisms, extensive characterization of their respective proteins and their responses to
allosteric ligands has yet to be performed for many.  However, the amino acid sequences
of several phosphofructokinases show significant similarity and thereby a highly
probable conservation of function.
Since our interest lies in understanding allosteric regulation in bacterial
phosphofructokinases, we study phosphofructokinases from E. coli (EcPFK), Bacillus
stearothermophilus (BsPFK) and Thermus thermophilus (TtPFK).  The sequence
alignments show a 41% identity and 59% similarity between the three enzymes.  These
three proteins are homotetramers of similar size and function.  Kinetic experiments
performed with these enzymes (Johnson and Reinhart, 1994, 1997; Tlapak-Simmons and
Reinhart, 1994; Xu et al., 1990) show that they respond to MgADP activation and PEP
inhibition of F6P binding.  High-resolution crystal structures of EcPFK and BsPFK show
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the binding site residues to be almost identical (Shirakihara and Evans, 1988; Schirmer
and Evans, 1990).  Therefore, these three allosteric phosphofructokinases show
significant similarities in sequence, structure and function.
In contrast, PFK from Lactobacillus delbrueckii subspecies bulgaricus (LbPFK),
as characterized in the previous chapter, shows no MgADP activation and minimal PEP
inhibition. The amino acid sequence of LbPFK is 47% identical and 66% similar to that
of EcPFK, 56% identical and 74% similar to that of BsPFK, and 48% identical and 65%
similar to that of TtPFK.  Interestingly, there are twenty-two residues that are conserved
in the three allosteric enzymes but not in LbPFK.  We hypothesize that these differences
in amino acid residues are crucial for the lack of allosteric response observed in LbPFK.
In order to address this hypothesis, we have introduced these differences individually
into EcPFK and studied the allosteric behavior of these mutant proteins as compared to
wildtype EcPFK.
Materials and Methods
Materials.  All chemical reagents used for protein purification and enzymatic
assays were obtained as described in Chapter II.  The following oligonucleotides were
ordered from Integrated DNA Technologies (IDT) to be used for mutagenesis:
V24T: CAG-CGC-AGA-ACG-AGT-AAC-CCC-GCG-AAT-TGC-GGC-G
D59H: GCC-ACG-GTT-GAT-CAT-GTG-AGA-AAC-GCT-GTA-ACG-G
R63V: CCG-AGG-AAC-GTA-CCG-CCA-ACG-TTG-ATC-ATG-TCA-GAA-ACG-C
G64S: CCG-AGG-AAC-GTA-CCG-CTA-CGG-TTG-ATC-ATG-TCA-GAA-ACG-C
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E114R: CGG-GAA-GCC-CAT-GCG-GGT-CAG-ACG-CAT-TGC-ACC-C
P118N: CGG-CAG-GCC-GAT-GCA-GTT-GAA-GCC-CAT-TTC-GG
G132Y: CCG-ATA-GTG-TAG-TCA-GTG-TAT-TTG-ATG-TCG-TTG-TCG
Y135A: CGC-AGT-GAA-GAA-ACC-GAT-AGT-CGC-GTC-AGT-GCC-TTT-GAT-
GTC-G
L143C: CGC-TTC-TAC-AAC-GGT-GCT-GCA-CGC-AGT-GAA-GAA-ACC-G
V147M: CGG-TCG-ATC-GCT-TCC-ATA-ACG-GTG-CTC-AGC-G
E167N: CCA-CAA-TAA-CGG-CCC-ATC-ACG-TTC-ACC-ACG-GAA-ATA-CGC
L178M: CCG-GCA-ATG-GCC-GCA-GCC-ATC-GTC-AGA-TCG-CCA-C
G184A: CGA-ATT-CAC-AGC-CAG-CGG-CAA-TGG-CCG-C
G184C: CGA-ATT-CAC-AGC-CAC-AGG-CAA-TGG-CGC-C
G184S: CGA-ATT-CAC-AGC-CAC-TGG-CAA-TGG-CCG-C
K211S: CGC-GTG-TTT-TTT-ACC-GCT-CGC-GAT-ACC-GCG
K214D: CGC-CAC-GAT-CGC-GTG-GTC-TTT-ACC-TTT-CGC-G
A231M: CTC-GAT-GAA-ATG-CAT-CAG-TTC-GTC-AAC-ATC-ACA-C
T245N: GCG-CTG-GAT-GTG-GCC-CAG-CAC-ATT-TGC-GCG-GGT-TTC-ACG-
ACC-GG
I250M: CCA-CCG-CGC-TGC-ATG-TGG-CCC-AGC-AC
A269S: GCA-GAT-CGA-TAG-CGT-AGC-TGC-CCA-TAC-GGG-AAG-CC
D273A: CCT-GCC-AGC-AGC-AGA-GCG-ATA-GCG-TAA-GCG-CC
D273H: GCC-AGC-AGC-AGA-TGG-ATA-GCG-TAA-GCG-CC
D273N: CCT-GCC-AGC-AGC-AGA-TTG-ATA-GCG-TAA-GCG-CC
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C283A: CGT-TCT-GTA-TAC-CTA-CAG-CAC-GAC-CGC-CGT-AAC-CTG-CC
I300F: CGC-TTC-ATG-TTT-TCG-AAA-GCG-TCG-ATG-ATG-TCG
Methods.  Altered Sites II in vitro Mutagenesis system from Promega was
performed on pGDR16 (Johnson et al, 2001) using the above-mentioned
oligonucleotides to introduce site-specific substitutions in EcPFK.  Each mutation was
confirmed by sequencing over the region of interest.  The mutated plasmids were
transformed into DF1020 cells (Daldal, 1983) and grown in 1.5 L LB broth in the
presence of 0.1 mg/mL ampicillin.  The cells were grown for 24 hours before harvested
and stored at –20°C until ready to be purified.  Purification of each mutant protein using
Mimetic Blue-1 resin and its kinetic characterization was performed at pH 8.0 and 25°C
as described in Chapter II.
Results and Discussion
The sequence alignment shown in Figure 5-1 between phosphofructokinases
from E. coli, B. stearothermophilus, T. thermophilus and L. bulgaricus reveal twenty-
two amino acid residues that are conserved between all but that from L. bulgaricus.
These residues in EcPFK were substituted for their counterpart from LbPFK in order to
study the role of these non-conserved residues in allosteric communication within
EcPFK.  The twenty-two constructs were created and their respective proteins were
purified to homogeneity.  The designation of each mutant protein was based on its amino
acid sequence in EcPFK and the substitution at that position from EcPFK to LbPFK,
e.g., V24T: the residue valine at position 24 has been substituted by threonine.  All the
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FIGURE 5-1: Amino acid sequence alignment for PFKs from E. coli (EcPFK), B.
stearothermophilus (BsPFK), T. thermophilus (TtPFK) and L. delbrueckii subspecies
bulgaricus (LbPFK).  Residues highlighted by grey shading are identical, while residues
highlighted by light gray shading are similar.  The asterisks in red represent the positions
where the single substitutions are located.
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twenty-two mutant proteins (V24T, D59H, R63V, G64S, E114R, P118N, G132Y,
Y135A, L143C, V147M, E167N, L178M, G184C, K211S, K214D, A231M, T245N,
I250M, A269S, D273H, C283A and I300F) were characterized for binding affinities and
allosteric responses to MgADP and PEP as compared to wildtype EcPFK at pH 8.0 and
25°C.  All the data obtained for the twenty-two mutant proteins are summarized in Table
5-1.
As shown in Figure 5-2, many of the non-conserved residues, R63, G64, L143,
V147, T245, I250, A269 and D273, lie at subunit interfaces.  Two residues, E114 and
P118, are at the surface with their side-chains facing outwards in the crystal structure.
Three residues, D59, K211 and K214, lie in the allosteric site and are within hydrogen-
bonding distance with MgADP (Figure 5-3).  The remaining residues, V24, G132, Y135,
E167, L178, G184, A231, C283 and I300, are in the interior of the protein.
Enzymatic Activity.  Under the same conditions, all of the purified mutant
proteins were active with specific activities comparable to that of wildtype, except for
G64S, P118N and G132Y.  These three mutant proteins are less active by an order of
magnitude as compared with wildtype.  G64 is located at the subunit interface,
substituting that residue to a serine could weaken the subunit interface and cause
dissociation of the tetramer and loss of activity.  P118 is found in at the surface whereas
G132 is in the interior of the protein.  The introduction of a bulky side chain could
disrupt proper folding, causing lower specific activities for the mutant proteins.
F6P Binding.  The binding affinities of F6P to many of the mutant proteins are
within two-fold to that of wildtype EcPFK.  The greatest effects were observed for G64S
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TABLE 5-1: Kinetic parameters for EcPFK mutants under standard assay conditions.
Vmax
(U/mg)
K0.5o
(mM)
Kixo
(mM)
Kiyo
(mM)
Qax Qay
Wildtype 330±3 0.30±0.01 0.10±0.01 0.30±0.01 12.7±0.3 0.0083±0.0003
V24T 400±5 0.52±0.01 0.061±0.002 0.37±0.01 15.6±0.2 0.0069±0.0002
D59H 480±5 2.51±0.03 1.22±0.33 4.90±0.40 1.53±0.04 0.41±0.01
R63V 250±5 0.55±0.01 0.16±0.01 0.87±0.02 22.9±0.9 0.0088±0.0006
G64S 26±1 7.40±0.17 0.15±0.03 0.41±0.03 4.18±0.24 0.024±0.002
E114R 200±5 1.25±0.02 0.12±0.01 0.42±0.01 11.4±0.3 0.032±0.001
P118N 22±1 0.39±0.01 0.13±0.01 0.64±0.01 7.19±0.20 0.036±0.001
G132Y 35±1 0.51±0.01 0.19±0.01 0.26±0.01 20.6±0.5 0.020±0.001
Y135A 350±5 0.25±0.01 0.038±0.003 0.14±0.01 7.44±0.26 0.0096±0.0001
L143C 480±2 0.51±0.01 0.11±0.01 0.27±0.01 15.8±0.5 0.011±0.001
V147M 180±5 0.21±0.01 0.080±0.003 0.29±0.01 8.27±0.13 0.0083±0.0002
E167N 275±5 1.42±0.03 0.17±0.01 0.29±0.01 38.7±1.3 0.010±0.001
L178M 270±5 0.63±0.01 0.24±0.01 0.33±0.01 21.5±0.4 0.025±0.001
G184C 160±5 0.070±0.001 0.010±0.002 7.06±0.34 3.24±0.06 0.064±0.007
K211S 195±5 0.45±0.01 0.10±0.01 24.2±2.0 12.6±0.2 N. D.a
K214D 340±7 0.77±0.01 1.12±0.04 8.74±0.83 22.1±0.5 0.49±0.01
A231M 190±5 0.84±0.01 0.14±0.01 0.40±0.01 35.7±0.6 0.011±0.001
T245N 500±10 0.60±0.02 0.093±0.001 0.20±0.01 20.6±0.9 0.0087±0.0004
I250M 190±5 2.27±0.03 0.15±0.01 0.24±0.01 34.8±.8 0.0081±0.0005
A269S 190±5 0.47±0.01 0.10±0.01 0.25±0.01 20.3±0.6 0.011±0.001
D273H 250±10 0.32±0.01 0.094±0.004 0.55±0.02 6.59±0.16 0.075±0.003
C283A 120±3 0.58±0.01 0.18±0.01 0.37±0.01 21.2±0.4 0.013±0.001
I300F 260±10 0.21±0.01 0.28±0.01 0.40±0.01 7.82±0.17 0.014±0.001
a Cannot be determined
The residues in red show significant decreases in binding affinities and allosteric properties.
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FIGURE 5-2: Location of the non-conserved residues in the crystal structure of EcPFK.
The crystal structure of EcPFK, generated using the program InsightII, as determined by
Shirakihara and Evans, 1988.  The non-conserved residues are shown in yellow in the
black subunit and are labeled in black.  MgADP and fructose-1,6-bisphosphate, are
shown in blue and red, respectively.
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FIGURE 5-3: The allosteric sites of EcPFK and LbPFK.  A superimposition of the
crystal structures of EcPFK (grey) and LbPFK (purple) as determined by Shirakihara
and Evans, 1988 and Paricharttanakul et al. (in prep).  Residues at position 59, 211 and
214 in the allosteric site are labeled.  The figures were generated on Insight II program.
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with a twenty-five fold weaker binding affinity for F6P, and for D59H and I250M with
eight-fold weaker binding affinities for F6P.  F6P binding to E114R, E167N and A231M
was four-fold weaker, however, a four-fold tighter binding was obtained for G184C.
Interestingly of all the mutants that exhibited altered binding affinity of F6P, only the
residue Glu167 lies within 9Å from the active site.  Therefore, introducing mutations to
the other residues must have caused long-range effects within the protein to affect
binding to the active site.
Cooperativity in F6P Binding.  In wildtype EcPFK, positive cooperativity is
observed for F6P binding in the presence of saturating MgATP.  This cooperativity, as
measured by the Hill number, remains unchanged in the presence of PEP but diminishes
in the presence of MgADP.  This phenomenon is observed for all mutants characterized
in this study except for D59H, in which the Hill number does not decrease as a function
of MgADP as shown in Figure 5-4.
MgADP Binding.  D59H and K214D bind MgADP with an order of magnitude
weaker than wildtype EcPFK (Figure 5-5).  It is not surprising that these two mutant
proteins bind MgADP weaker since both residues lie within the allosteric site (Figure 5-
3).  However, we should expect an increase in the binding affinity D59H has for
MgADP instead of a decrease because of the favorable attraction of the positively
charged side-chain with the negatively charged ligand.  On the other hand, there could
be steric hindrance caused by the substitution of an imidazole ring in place of the
carboxylic group, introduced by the mutation at position 59.  The presence of this bulky
side chain could inhibit the binding of MgADP to the allosteric site.  At position 214,
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FIGURE 5-4: Homotropic cooperativity as a function of MgADP.  ° and ® represent
wildtype EcPFK and D59H, respectively.  In the presence of MgADP, the Hill number
remains unchanged for D59H unlike wildtype.
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FIGURE 5-5: Comparison of mutant proteins to wildtype EcPFK in their responses to
MgADP.  The apparent dissociation constant for F6P was determined and plotted as a
function of MgADP concentration. °, ® and Ø represent wildtype EcPFK, D59H and
K214D, respectively.
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there could be charge repulsion between the phosphate group of MgADP and the
negative charge of the aspartate residue if MgADP were to bind as in wildtype.  All the
other mutants bind MgADP within two-fold of wildtype except for G184C and Y135A
with more than a three-fold tighter binding affinities for MgADP.  On the other hand,
L178M and I300F both bind MgADP weaker by about three-fold than wildtype.
PEP Binding.  The binding affinities for PEP are weaker by an order of
magnitude for D59H, G184C, K211S and K214D (Figure 5-6).  Lys211 lies in the
allosteric site with Asp59 and Lys214 (Figure 5-3).  The shortening of the side chain at
position 211 and the removal of the positive charge would probably still allow proper
contacts to be made with MgADP but not with PEP, since PEP is a smaller molecule
than MgADP.  Gly184 is in the interior of the protein and is within 9Å from the MgADP
at the allosteric site.  The addition of the cysteine side chain causes some conformational
change within the protein that allows for the tighter binding of F6P, MgADP but not
PEP.
MgADP Activation.  D59H, G184C and G64S show reduced MgADP activation
by eight-fold, four-fold and three-fold, respectively.  There is a three-fold increase in
activation for E167N and A231M, which probably mean that the extent of activation by
MgADP to wildtype EcPFK is not the upper limit.  The conformational changes that
have occurred within the mutant proteins might have allowed for the enhanced activation
observed.  MgADP activation for all the other mutants was within two-fold to that of
wildtype.  One would think that K214D would show a decrease in activation, due to a
weaker binding affinity for MgADP.  Since this is not the case, there can be no parallel
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FIGURE 5-6: Comparison of mutant proteins to wildtype EcPFK in their responses to
PEP.  The apparent dissociation constant of F6P was plotted as a function of PEP
concentration.  °, ®, Ø, r and s represent wildtype EcPFK, D59H, G184C, K211S
and K214D, respectively.
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drawn between weaker binding and weaker activation or inhibition, and vice versa as
seen before (Tlapak-Simmons and Reinhart, 1998; Fenton et al., 2003).
PEP Inhibition.  The mutations in the allosteric site, D59H and K214D,
decreased PEP inhibition by fifty-fold.  Unfortunately, the extent of PEP inhibition
forK211S cannot be determined due to the inability to saturate the allosteric effect.
G184C and D273H have diminished inhibition by eight-fold and nine-fold, respectively.
A four-fold weaker inhibition by PEP is observed for E114R, P118N and L178M as
compared to wildtype.
These data show that the residues important for MgADP activation and PEP
inhibition are different.  D59H seems to be important for both types of allosteric effects.
K214D, on the other hand, is only important for PEP inhibition but not MgADP
activation.  There could be a region close to the allosteric binding site that is involved in
relaying information for inhibition and another for activation, with a region of
overlapping influence.  In other words, allosteric communication travels via different
paths within the protein as previously suggested (Auzat et al, 1995, Fenton et al., 2003).
Stability.  G184C is not stable under low concentrations and D273H has a
specific activity that decreases over time.  These single substitutions destabilize the
proteins, probably causing dissociation of the tetramer thereby losing activity as a result.
Gly184 lies in the interior of the protein and is close to the allosteric site, whereas
Asp273 lies in the subunit interface (Figure 5-7).  These two mutations are interesting
because of their unique behavior in binding and allostery.  G184C binds F6P tighter by
almost four-fold, binds PEP weaker by more than 20-fold but binds MgADP tighter by
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FIGURE 5-7: The location of residues at position 184 and 273 with respect to the
allosteric site.  A superimposition of the crystal structures of EcPFK (grey) and LbPFK
(purple) as determined by Shirakihara and Evans, 1988 and Paricharttanakul et al (in
prep).  Residues at position 184 are within 9Å and residues at position 273 are 20Å away
from ADP in the allosteric site.  The figures were generated on Insight II program.
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more than four-fold than to wildtype.  Moreover, G184C has an eight-fold weaker PEP
inhibition and a three-fold lower activation by MgADP than wildtype.  D273H binds
F6P with the same affinity, binds PEP and MgADP almost two-fold weaker than
wildtype.  D273H has a nine-fold weaker inhibition by PEP and a two-fold lower
activation by MgADP than wildtype.  These results further support that there is no
correlation between binding and allostery; weaker binding does not necessitate a weaker
allosteric effect.
More conservative mutations were created in order to increase the stability of the
proteins.  At position 273, aspartate was substituted with alanine and asparagine, instead
of with histidine (Figure 5-8).  These proteins behave very similarly to wildtype,
including stability. F6P, PEP and MgADP binding to each of the mutant proteins were
not affected to a great extent.  PEP inhibition and MgADP activation of D273A and
D273N are within two-fold of wildtype.  At position 184, glycine was substituted with
alanine and serine, instead of with cysteine (Figure 5-9).  Instability was not a problem
for these mutants.  When compared to wildtype EcPFK, binding of F6P to G184A and
G184S is very similar.  MgADP binding is two-fold weaker for G184A, with not much
difference for G184S and wildtype.  Binding of PEP to G184A and G184S is two-fold
and five-fold tighter than wildtype, respectively.  Interestingly, there seems to be a trend
with MgADP activation and PEP inhibition to varying extents with each substitution.
Substituting the hydrogen atom with a methyl group at position 184 decreases both
activation and inhibition.  The addition of a hydroxyl group to the methyl group, then
substituting a heavier atom from oxygen to sulfur further shows a decrease to the extent
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FIGURE 5-8: The importance of specific substitutions at position 273.  The apparent
dissociation constant for F6P was plotted as a function of MgADP (A) and PEP (B) for
wildtype EcPFK (°), D273A (®), D273H (r) and D273N (Ø).
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FIGURE 5-9: The importance of specific substitutions at position 184.  The apparent
dissociation constant for F6P was plotted as a function of MgADP (A) and PEP (B) for
wildtype EcPFK (°), G184A (®), G184S (r) and G184C (Ø).
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of allostery.  These results show that side chains are important for transmitting allosteric
information through the protein.
Conclusions
Twenty-two mutant proteins were created to find residues crucial for binding of
allosteric ligands and/or allosteric communication in phosphofructokinase from E. coli
based on the sequence of phosphofructokinase from L. bulgaricus.  Five mutant proteins
show interesting characteristics.  MgADP binding was diminished in D59H and K214D.
The binding affinity for PEP was greatly reduced in D59H, G184C, K211S and K214D.
All these residues lie within the allosteric site as shown in Figure 5-5, except for Gly184
that is close to that site.  It is therefore not surprising that mutations in or near the
allosteric site affect binding at the allosteric site.  In addition, allosteric responses to
MgADP and PEP are diminished in D59H, G184C and D273H.  No significant reduction
in the binding affinities for MgADP and PEP to D273H was observed.  K211S did not
exhibit any decrease in MgADP activation, however, the extent of PEP inhibition could
not be determined.  The most interesting result is that in K214D, no effect was observed
on MgADP activation however, PEP inhibition was reduced as compared to wildtype.
This suggests that PEP inhibition and MgADP activation is transmitted through the
protein via different paths.
Out of the five, there were two mutant proteins not in the allosteric site that have
decreased allosteric responses to MgADP and PEP.  As shown in Figure 5-7, Gly184 lies
in the interior of the protein but close to the allosteric site.  Asp273 lies at the subunit
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interface and is approximately 20Å away from the allosteric site.  These two residues
could be important for the transmission of allosteric information.  However, G184C
loses activity at low protein concentrations and the activity of D273H is lost within a
week.  To minimize instability, additional mutant proteins were created in order to get
more stable mutant proteins of Gly184 and Asp273 by introducing more conservative
mutations.  Unfortunately, these mutant proteins do not differ significantly from
wildtype unlike G184C or D273H.  Therefore, specific substitutions are important for
determining the loss of allosteric response.  Further experiments need to be performed to
definitively identify the role of these two mutations, G184C and D273H, in the relay of
allosteric information.
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CHAPTER VI
PINPOINTING THE ROLE OF GLY184 IN THE UNIQUE
HETEROTROPIC INTERACTIONS IN
PHOSPHOFRUCTOKINASE FROM ESCHERICHIA COLI
Introduction
EcPFK is a homotetramer with four active sites and four allosteric sites in which
each site can interact with one another.  This multiplicity of interactions can be
simplified using the hybrid tetramer approach to isolate a single interaction between one
active site and one allosteric site (heterotropic interaction).  There are four unique
heterotropic interactions possible in EcPFK, and each interaction has been quantified for
its contribution to the allosteric responses of the enzyme to MgADP and PEP as
described in Chapter III and Fenton et al., 2004.  In this study, we want to ascertain
whether we can differentially disrupt the heterotropic interactions with a mutation in the
interior of the protein that has been shown to perturb the overall allosteric effect in the
enzyme.
In the previous chapter, we have identified two residues in EcPFK that seem to
be important in enabling PEP inhibition and MgADP activation.  Gly184 and Asp273,
when substituted with their counterparts from LbPFK show decreased allosteric effects
by PEP and MgADP.  At 25°C, G184C exhibits an eight-fold weaker PEP inhibition and
a three-fold lower activation by MgADP than wildtype EcPFK.  Similarly, D273H has a
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nine-fold weaker inhibition by PEP and a two-fold lower activation by MgADP than
wildtype.  Asp273 is found at the subunit interface and is 20Å from the allosteric site.
Gly184 is 9Å away from the allosteric site and is in the interior of the protein.  Due to its
location in the protein and the greater stability G184C exhibits compared to D273H, we
introduced G184C into each of the four heterotropic interactions to investigate more
thoroughly how allosteric information is transmitted in phosphofructokinase from E.
coli.  These experiments would reveal the importance of Gly184 in the four heterotropic
interactions and whether allosteric information is transmitted in a subset of interactions
or via the whole protein.
Materials and Methods
Materials.  All chemical reagents used for protein purification and enzymatic
assays were obtained as described in Chapter II.  G184C and the constructs in Table 3-1
were created using Promega Altered Sites Mutagenesis and Stratagene QuikChange
protocols.
Methods.  The purifications of G184C, the 30Å and 33Å mutant proteins follow
that described in Chapter II.  Additional considerations were given to the 23Å and 45Å
mutant proteins.  The 45Å mutant protein is sensitive to temperature and must be kept at
4°C throughout purification and further manipulation.  Expression of the 23Å mutant
protein was very poor, purification from a total of 24 L cell culture was needed.
Hybrid tetramers of EcPFK containing G184C were created using a modified
protocol from Chapter III (Figure 6-1).  3 mg G184C was incubated with 10 mg of 23Å,
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FIGURE 6-1: Strategy used to create hybrid tetramers of EcPFK containing G184C.
The 1:3 hybrid tetramer (boxed in red) contains only one unique heterotropic interaction
that contains G184C.
111
30Å, 33Å or 45Å mutant proteins in the presence of 0.35M to 0.5M KSCN for 1.5 hours.
The proteins were dialyzed into Buffer A + 2 mM F6P with an hour between each buffer
change for a total of three hours at 4°C.  The dialyzed proteins were loaded onto the
MonoQ column on Pharmacia FPLC and each hybrid tetramer species was separated
with a salt gradient as shown in Figure 6-2A.  Additional F6P (up to 20mM) was added
to the 1:3 hybrid to prevent rehybridization.  The identity and purity of each hybrid
species were confirmed on a 7.5% native PAGE as shown in Figure 6-2B.
G184C and the isolated 1:3 hybrid proteins that contained G184C were
characterized for their allosteric behavior with regards to MgADP and PEP at 8.5°C and
were subject to the same kinetic analyses performed in Chapter II and III.
Results and Discussion
G184C shows a three-fold decrease in MgADP activation and a two-fold
decrease in PEP inhibition as compared to wildtype EcPFK at 8.5°C (Figure 6-3).
Introduction of this mutation into each of the four unique heterotropic interactions via
the hybrid tetramer approach shown in Figure 6-1 has been successfully utilized in three
of the four interactions.  For the three successful hybrid tetramer formations, isolation of
each of the 1:3 hybrids yields a protein that contains a single heterotropic interaction
with the mutation G184C as seen in Figure 6-2.
Each of the three heterotropic interactions was characterized for the effects of
MgADP and PEP as shown in Figure 6-4.  The 30Å and 45Å interactions show
substantial MgADP activation, with minimal activation in the 33Å interaction.  There is
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FIGURE 6-2: Separation and isolation of the 30Å heterotropic interaction containing
G184C.  A) Elution profile off MonoQ FPLC.  Each hybrid tetramer was separated
based on its charge composition with a salt gradient.  The arrow shows the peak
containing the 1:3 hybrid tetramer. B) 7.5% native gel of each peak fraction.  These are
representative of the 33Å and the 45Å heterotropic interactions.
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FIGURE 6-3: The allosteric effect of MgADP and PEP on G184C as compared to
wildtype EcPFK at 8.5°C.  The empty and shaded bars represent data of wildtype and
G184C, respectively.
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FIGURE 6-4: The influence of MgADP (A) and PEP (B) on three of the four
heterotropic interactions.  °, ®  and Ø  represent data for the 33Å, 30Å and 45Å
interaction, respectively.  The lines represent fits to equation 2-2 from Chapter II.
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a slight activating effect of PEP on the 33Å interaction, and some inhibitory effect on the
30Å and the 45Å interactions.  These data show that each interaction is unique and that
MgADP and PEP affect each interaction differently.  Figure 6-5 and Table 6-1 show the
comparison of the allosteric effects in the heterotropic interactions in wildtype EcPFK
with that containing G184C.  G184C increases activation by MgADP by two-fold in the
30Å interaction, but substantially decreases activation in the 33Å interaction by five-fold
as compared to wildtype.  G184C does not appreciably affect PEP inhibition on the three
interactions investigated.
No hybrids were observed for G184C and the 23Å mutant even when denaturant
concentration and/or incubation time was increased (Figure 6-6).  Hybrid tetramers have
been successfully created between wildtype and the 23Å mutant (Fenton et al., 2004)
and between G184C and each of the other three mutants in our study.  Since there is
evidence that KSCN can dissociate G184C and the 23Å mutant, it is therefore
reasonable to conclude that either hybrids cannot be created between these two proteins
or are too unstable to be detected under our experimental conditions.
We can hypothesize that the two-fold decrease in PEP inhibition observed in the
G184C tetramer as compared to wildtype could be found in the 23Å interaction since it
was not present in the other three interactions, assuming all four interactions are
additive.  Moreover, since there is a three-fold decrease in MgADP activation observed
in the G184C tetramer, it is all accounted for in the 33Å and 30Å interactions.  We
would therefore not expect to see a change in the extent of MgADP activation in the 23Å
interaction in the presence of G184C.  It is really unfortunate that we cannot form the
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FIGURE 6-5: Distribution of the allosteric effect in the four heterotropic interactions in
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interactions contained in wildtype and G184C, respectively for the effect of MgADP (A)
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TABLE 6-1: Coupling constants for each of the four heterotropic interactions at 8.5°C.
Qax
Wildtype
Qax
G184C
Qay‡
Wildtype
Qay
G184C
33Å 6.4 ± 0.2 1.2 ± 0.1 1.4 ± 0.1 1.1 ± 0.2
30Å 3.0 ± 0.2 5.9 ± 0.6 0.27 ± 0.02 0.20 ± 0.07
45Å 2.9 ± 0.2* 2.3 ± 0.6 0.35 ± 0.01 0.36 ± 0.07
23Å 3.6 ± 0.2* N.D. 0.17 ± 0.02 N.D.
* Data obtained from Fenton et al., 2004
‡ Data obtained from Fenton and Reinhart (unpublished)
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FIGURE 6-6:  No formation of the 23Å interaction.  A 7.5% native gel was run on
samples of G184C and the 23Å mutant protein at various concentrations of KSCN.
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23Å interaction to validate our hypothesis.  However, we have sufficient information to
support our conclusion yet again that PEP inhibition and MgADP activation follow
different paths within the protein, with the 33Å interaction being very important for
MgADP activation.  Finally, we have successfully disrupted activation but not inhibition
in the 33Å interaction with the introduction of the mutation at position 184. The crystal
structure of EcPFK could reveal a possible explanation into why Gly184 is important in
the 33Å interaction.  Figure 6-7 shows the location of Gly184 with respect to the four
heterotropic interactions.  This residue lies directly in between the sites in the 33Å
interaction.  This could explain why mutating this residue to cysteine interrupted the
33Å interaction.  Moreover, the effect of this mutation is differentially manifested in the
different MgADP interactions.  However, there was no effect of this mutation on the
three PEP interactions studied.
Conclusions
Introduction of G184C into three of the four heterotropic interactions in
phosphofructokinase in E. coli was successful and kinetic characterization have provided
insight into the mode of transmission of allosteric information within the enzyme.  There
is certainly a different path of communication for activation by MgADP and inhibition
by PEP.  Moreover, we have determined the Gly184 is important in MgADP activation
in the 33Å interaction, possibly because this residue lies directly between the sites in the
33Å interaction.  Interestingly, this residue does not seem to be important for PEP
inhibition.
120
FIGURE 6-7:  Location of G184C in the four heterotropic interactions of EcPFK.
Subunit A is shown on the left and the heterotropic interactions denoted by their
distances in the crystal structure.  Fructose-1, 6-bisphosphate, MgADP and G184C are in
red, blue and yellow, respectively.
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We cannot really compare our heterotropic results to that of the tetrameric
G184C.  There is homotropic cooperativity in F6P binding in G184C like wildtype, but
not in the unique heterotropic interactions (Fenton and Reinhart, 2002).  Additional
experiments need to be performed to eliminate homotropic cooperativity in G184C.
Moreover, we cannot check additivity in the extent of allosteric responses to MgADP
and PEP in the interactions containing G184C since we could only create and
characterize three of the four unique interactions.  Additivity in the coupling free
energies of the four heterotropic interactions have been observed in wildtype EcPFK
(Fenton et al., 2004) and wildtype PFK from Bacillus stearothermophilus (Ortigosa et al,
2003) after homotropic cooperativity is accounted for.
We have assumed that allosteric communication in the 1:3 hybrid proceeds
through the subunit containing G184C, and not communicated through the other three
subunits.  This may or may not be the case; the perturbations caused by G184C on the
tetramer can be localized within that subunit or throughout the whole tetramer.  Another
set of experiments could be performed to put G184C in all four subunits.  This would
eliminate the need for any assumptions.  These experiments however, would be harder to
perform due to the decrease in stability with the addition of G184C on all subunits.
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CHAPTER VII
CONCLUSIONS
Extensive kinetic, mutagenic and structural studies have been performed to study
allosteric regulation in phosphofructokinase from Escherichia coli (Blangy et al., 1968;
Shirakihara and Evans, 1988; Johnson and Reinhart, 1994, 1997; Wang and Kemp,
1999; Pham and Reinhart, 2001; Fenton et al., 2003).  However, a more thorough
investigation into the path and/or residue(s) important for allosteric communication in
this enzyme has yet to be conducted.
In Chapter III, we created hybrid tetramers to simplify the allosteric web of
potential interactions present in EcPFK.  In collaboration with Dr. Aron Fenton, we have
successfully characterized all four unique heterotropic interactions with respect to
MgADP activation in the homotetramer (Fenton et al., 2004).  Each interaction is unique
in magnitude and they combine additively to the total heterotropic effect observed in the
tetramer that has homotropic cooperativity of F6P removed.  A similar result was
obtained for the effect of PEP on the four unique heterotropic interactions in PFK from
B. stearothermophilus (Ortigosa et al., 2003).
Chapter IV describes the kinetic and structural characterization of PFK from L.
bulgaricus.  The 1.86Å resolution crystal structure of LbPFK reveals a fold similar to
that of EcPFK and BsPFK.  The residues that contact both substrates are conserved
however, the residues in the allosteric site are not.  This could explain why the binding
of either MgADP or PEP to LbPFK is very weak as compared to EcPFK and BsPFK.
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Moreover, allosteric effects by PEP and MgADP are observed, both slightly inhibitory to
F6P binding.  This is in contrast to the study performed by Le Bras et al., 1991.  We
conclude that the enzyme has some allosteric control at very high concentrations of
MgADP and PEP but not to the same extent of EcPFK and BsPFK.
To address the question on which residue in EcPFK is important for enabling
allosteric communication (Chapter V), we took advantage of published amino acid
sequences of EcPFK, BsPFK, TtPFK and LbPFK  All but PFK from L. bulgaricus
respond to MgADP activation and PEP inhibition of F6P binding at pH 8.0 (Xu et al.,
1990; Le Bras et al., 1991; Johnson and Reinhart, 1994, 1997; Tlapak-Simmons and
Reinhart, 1998).  Our experiments from Chapter IV have shown no MgADP activation
and slight PEP inhibition in LbPFK.  Sequence alignment of these four enzymes reveal
twenty-two residues that are conserved in the three allosteric PFKs but not LbPFK.
Each of the twenty-two residues in EcPFK was substituted for its counterpart from
LbPFK and characterized for its responses to MgADP and PEP.  Three residues when
mutated (D59H, G184C and D273H) show significant reductions in the magnitude of
PEP inhibition and MgADP activation.  K214D, however, reduced the extent of PEP
inhibition and not MgADP activation.  This lysine residue at position 214 seems to be
important for only PEP inhibition.  Therefore, we can conclude that paths of allosteric
communication for inhibition and activation are different, which was also observed in
Fenton et al., 2003.
The question now arises to be whether these reductions in allosteric response are
differentially manifested in the heterotropic interactions in EcPFK (Chapter VI).  To
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study the effect of these mutations on the heterotropic interactions, we introduced only
G184C into the hybrid tetramers since Gly184 is in the interior of the protein and 9Å
from the allosteric site.  The other three did not fit our criteria of being in the interior of
the protein.  Asp59 and Lys214 lie in the allosteric site and Asp273 is solvent exposed.
Unfortunately, we can only create and characterize three of the four unique heterotropic
interactions containing G184C.  However with the three isolated, we have determined
that Gly184 is important for MgADP activation via the 33Å interaction, but not
inhibition.  Once again, we have established that PEP inhibition and MgADP activation
of F6P binding are communicated in different paths in the enzyme.
Additional experiments need to be performed to identify residues that make up
the paths of allosteric communication by MgADP and PEP.  We have identified four
residues, Asp59, Gly184, Lys214 and Asp273, which are important for allostery.  So far
Gly184 has been shown to be important for MgADP activation in only the 33Å
interaction.  The role of the other three residues in the unique heterotropic interactions is
still unknown.  This type of dissection into the transmission of allosteric information can
be performed to reveal more residues that play significant roles in the allosteric
communication pathway in EcPFK.
In summary, we have successfully simplified the allosteric web by characterizing
the four unique heterotropic interactions between MgADP and F6P binding sites, and
have identified some residues in EcPFK that are important in transmitting allosteric
information by PEP and MgADP.  One of these residues has differentially disrupted the
responses to MgADP in the heterotropic interactions but not to PEP.  Therefore, we have
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established that allosteric communication follows different pathways in EcPFK between
one active site and one allosteric site.  Moreover, the path is also different for MgADP
activation and PEP inhibition.
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